<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="ppub">1935-2727</issn><issn pub-type="epub">1935-2735</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6014677</article-id><article-id pub-id-type="pmid">29851968</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0006518</article-id><article-id pub-id-type="publisher-id">PNTD-D-17-01938</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Urine</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Urine</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Urine</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Urine</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>North America</subject><subj-group><subject>Central America</subject><subj-group><subject>Nicaragua</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Zoology</subject><subj-group><subject>Entomology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Extraction techniques</subject><subj-group><subject>RNA extraction</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Zika virus infection in Nicaraguan households</article-title><alt-title alt-title-type="running-head">Zika virus infection in Nicaraguan households</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Burger-Calderon</surname><given-names>Raquel</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gonzalez</surname><given-names>Karla</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ojeda</surname><given-names>Sergio</given-names></name><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zambrana</surname><given-names>Jos&#x000e9; Victor</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sanchez</surname><given-names>Nery</given-names></name><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cerpas Cruz</surname><given-names>Cristhiam</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Suazo Laguna</surname><given-names>Harold</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bustos</surname><given-names>Fausto</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Plazaola</surname><given-names>Miguel</given-names></name><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lopez Mercado</surname><given-names>Brenda</given-names></name><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Elizondo</surname><given-names>Douglas</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Arguello</surname><given-names>Sonia</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Carey Monterrey</surname><given-names>Jairo</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nu&#x000f1;ez</surname><given-names>Andrea</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Coloma</surname><given-names>Josefina</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Waggoner</surname><given-names>Jesse J.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gordon</surname><given-names>Aubree</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kuan</surname><given-names>Guillermina</given-names></name><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Balmaseda</surname><given-names>Angel</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7238-4037</contrib-id><name><surname>Harris</surname><given-names>Eva</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Sustainable Sciences Institute, Managua, Nicaragua</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Laboratorio Nacional de Virolog&#x000ed;a, Centro Nacional de Diagn&#x000f3;stico y Referencia, Ministry of Health, Managua, Nicaragua</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Medicine, Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia, United States of America</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Department of Epidemiology, School of Public Health, University of Michigan, Michigan, United States of America</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Centro de Salud S&#x000f3;crates Flores Vivas, Ministry of Health, Managua, Nicaragua</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Rimoin</surname><given-names>Anne</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of California, Los Angeles, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>eharris@berkeley.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2018</year></pub-date><volume>12</volume><issue>5</issue><elocation-id>e0006518</elocation-id><history><date date-type="received"><day>6</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>10</day><month>5</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Burger-Calderon et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Burger-Calderon et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pntd.0006518.pdf"/><abstract><p>Zika virus (ZIKV) infection recently caused major epidemics in the Americas and is linked to congenital birth defects and Guillain-Barr&#x000e9; Syndrome. A pilot study of ZIKV infection in Nicaraguan households was conducted from August 31 to October 21, 2016, in Managua, Nicaragua. We enrolled 33 laboratory-confirmed Zika index cases and their household members (109 contacts) and followed them on days 3&#x02013;4, 6&#x02013;7, 9&#x02013;10, and 21, collecting serum/plasma, urine, and saliva specimens along with clinical, demographic, and socio-economic status information. Collected samples were processed by rRT-PCR to determine viral load (VL) and duration of detectable ZIKV RNA in human bodily fluids. At enrollment, 11 (10%) contacts were ZIKV rRT-PCR-positive and 23 (21%) were positive by IgM antibodies; 3 incident cases were detected during the study period. Twenty of 33 (61%) index households had contacts with ZIKV infection, with an average of 1.9 (range 1&#x02013;6) positive contacts per household, and in 60% of these households, &#x02265;50% of the members were positive for ZIKV infection. Analysis of clinical information allowed us to estimate the symptomatic to asymptomatic (S:A) ratio of 14:23 (1:1.6) among the contacts, finding 62% of the infections to be asymptomatic. The maximum number of days during which ZIKV RNA was detected was 7 days post-symptom onset in saliva and serum/plasma and 22 days in urine. Overall, VL levels in serum/plasma, saliva, and urine specimens were comparable, with means of 5.6, 5.3 and 4.5 log<sub>10</sub> copies/ml respectively, with serum attaining the highest VL peak at 8.1 log<sub>10</sub> copies/ml. Detecting ZIKV RNA in saliva over a similar time-period and level as in serum/plasma indicates that saliva could potentially serve as a more accessible diagnostic sample. Finding the majority of infections to be asymptomatic emphasizes the importance of silent ZIKV transmission and helps inform public health interventions in the region and globally.</p></abstract><abstract abstract-type="summary"><title>Author summary</title><p>Zika virus (ZIKV) infection has become a major concern due to its association with congenital birth defects and Guillain-Barr&#x000e9; Syndrome. We enrolled 33 laboratory-confirmed Zika cases (index cases) and their household members (109 contacts) in Managua, Nicaragua, and followed them for three weeks, collecting serum/plasma, urine and saliva specimens along with clinical, demographic, and socio-economic status information. We found that 61% of the index households had contacts with ZIKV infection, with an average of 1.9 (range 1&#x02013;6) positive contacts per household, and in 60% of these households, &#x02265;50% of the members were ZIKV-positive. Analysis of clinical information allowed estimating the symptomatic to asymptomatic (S:A) ratio of 14:23 (1:1.6) among the contacts. Finding 62% of the infections to be asymptomatic emphasizes the importance of silent transmission. Evaluating the maximum number of days during which ZIKV RNA was detectable showed that ZIKV was found up to 7 days post-symptom onset in serum/plasma and saliva and 22 days post-symptom onset in urine. Finding ZIKV RNA in saliva over a similar time period and concentration as serum/plasma indicates that saliva could potentially serve as a more accessible diagnostic sample. Overall, these data increase our understanding of ZIKV transmission and help inform public health interventions in the region and globally.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>P01AI106695</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7238-4037</contrib-id><name><surname>Harris</surname><given-names>Eva</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R01AI099631</award-id><principal-award-recipient><name><surname>Balmaseda</surname><given-names>Angel</given-names></name></principal-award-recipient></award-group><funding-statement>This research was funded by grants P01AI106695 (EH) and R01AI099631 (AB) from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="4"/><page-count count="19"/></counts><custom-meta-group><custom-meta><meta-name>PLOS Publication Stage</meta-name><meta-value>vor-update-to-uncorrected-proof</meta-value></custom-meta><custom-meta><meta-name>Publication Update</meta-name><meta-value>2018-06-22</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Zika virus (ZIKV) emergence in the Americas was first documented in northeastern Brazil in March of 2015 [<xref rid="pntd.0006518.ref001" ref-type="bibr">1</xref>, <xref rid="pntd.0006518.ref002" ref-type="bibr">2</xref>], although the virus may already have been introduced in 2014 [<xref rid="pntd.0006518.ref003" ref-type="bibr">3</xref>]. ZIKV spread rapidly throughout the Americas [<xref rid="pntd.0006518.ref004" ref-type="bibr">4</xref>], and the World Health Organization (WHO) declared Zika a Public Health Emergency of International Concern in February of 2016 [<xref rid="pntd.0006518.ref004" ref-type="bibr">4</xref>]. ZIKV infection in adults has been associated with Guillain-Barr&#x000e9; Syndrome [<xref rid="pntd.0006518.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pntd.0006518.ref006" ref-type="bibr">6</xref>], and infection during pregnancy can have devastating effects, including severe congenital birth defects such as microcephaly and other neurological and developmental sequelae [<xref rid="pntd.0006518.ref007" ref-type="bibr">7</xref>&#x02013;<xref rid="pntd.0006518.ref010" ref-type="bibr">10</xref>]. In Nicaragua, Zika was first confirmed in January of 2016, and the country experienced an explosive epidemic between June and September of 2016 [<xref rid="pntd.0006518.ref011" ref-type="bibr">11</xref>]. As of August 2017, 48 countries and/or territories in the Americas reported autochthonous vector-borne ZIKV transmission [<xref rid="pntd.0006518.ref012" ref-type="bibr">12</xref>].</p><p>Mathematical models suggest that a ZIKV-positive individual can lead to approximately 2&#x02013;5 additional infections via mosquito transmission [<xref rid="pntd.0006518.ref013" ref-type="bibr">13</xref>, <xref rid="pntd.0006518.ref014" ref-type="bibr">14</xref>]. ZIKV transmission is predominantly mosquito-borne, but sexual transmission has been reported as well [<xref rid="pntd.0006518.ref013" ref-type="bibr">13</xref>, <xref rid="pntd.0006518.ref015" ref-type="bibr">15</xref>, <xref rid="pntd.0006518.ref016" ref-type="bibr">16</xref>]. Salivary transmission has been deemed possible but unlikely [<xref rid="pntd.0006518.ref013" ref-type="bibr">13</xref>, <xref rid="pntd.0006518.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pntd.0006518.ref017" ref-type="bibr">17</xref>]. Viral transmission is thought to depend on viral load (VL) in bodily fluids [<xref rid="pntd.0006518.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="pntd.0006518.ref020" ref-type="bibr">20</xref>]; therefore, characterization of ZIKV VL kinetics in different compartments is of great interest. Although ZIKV viremia in humans is relatively low, ZIKV RNA has been detected in blood, urine, saliva, semen, and vaginal secretions [<xref rid="pntd.0006518.ref015" ref-type="bibr">15</xref>, <xref rid="pntd.0006518.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="pntd.0006518.ref023" ref-type="bibr">23</xref>]. While reported duration of VL in bodily fluids varies greatly, ZIKV RNA measured by real-time reverse transcription-PCR (rRT-PCR) has revealed detectable viral RNA up to 76 days post-symptom onset in semen, 29 days in saliva and urine, and 14 days in vaginal secretions and serum [<xref rid="pntd.0006518.ref002" ref-type="bibr">2</xref>, <xref rid="pntd.0006518.ref021" ref-type="bibr">21</xref>, <xref rid="pntd.0006518.ref022" ref-type="bibr">22</xref>, <xref rid="pntd.0006518.ref024" ref-type="bibr">24</xref>&#x02013;<xref rid="pntd.0006518.ref032" ref-type="bibr">32</xref>]. With the exception of one publication reporting detectable viral RNA in whole blood up to day 81 post-symptom onset [<xref rid="pntd.0006518.ref021" ref-type="bibr">21</xref>], ZIKV was shed the longest in semen [<xref rid="pntd.0006518.ref022" ref-type="bibr">22</xref>]. Symptomatic ZIKV infection has been associated with fever, conjunctivitis, rash, myalgia, arthralgia/arthritis, headache and fatigue, though fever may not always be present [<xref rid="pntd.0006518.ref032" ref-type="bibr">32</xref>]. Estimates of asymptomatic ZIKV infections range from 27% to 82% [<xref rid="pntd.0006518.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pntd.0006518.ref038" ref-type="bibr">38</xref>], though more studies are needed.</p><p>Household-based index cluster study designs, where household or neighborhood contacts of viremic index cases are recruited [<xref rid="pntd.0006518.ref039" ref-type="bibr">39</xref>], allow capture of symptomatic cases immediately at and before symptom onset, as well as capture of asymptomatic infections, household transmission events, geospatial spread of infection, and individual and household risk factors for infection, including entomological risk factors [<xref rid="pntd.0006518.ref040" ref-type="bibr">40</xref>&#x02013;<xref rid="pntd.0006518.ref043" ref-type="bibr">43</xref>]. Additional data on household transmission, the percentage of asymptomatic ZIKV infections, and risk factors for ZIKV infection are essential to inform officials making critical public health decisions targeting prevention of ZIKV transmission; furthermore, little information has been published from Central America. The present index household study was implemented in Managua, Nicaragua, from August 31 to October 21 of 2016 and aimed to investigate household ZIKV transmission, maximum duration of viral RNA detection in bodily fluids, kinetics of ZIKV VL levels in bodily fluids, the symptomatic to asymptomatic (S:A) ratio, and risk factors for ZIKV infection.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Methods</title><sec id="sec003"><title>Ethics statement</title><p>The Institutional Review Boards (IRB) of the University of California, Berkeley, and the Nicaraguan Ministry of Health approved the index cluster study protocol and the ongoing Nicaraguan Pediatric Dengue Cohort Study (PDCS). All adult participants provided written informed consent, and parents or legal guardians provided written informed consent for children participants. In addition, children between 6 and 18 years of age provided verbal assent.</p></sec><sec id="sec004"><title>Study design</title><p>During the study period, rRT-PCR-confirmed Zika cases (potential index cases) from either the Nicaraguan PDCS [<xref rid="pntd.0006518.ref044" ref-type="bibr">44</xref>] or the general population (National Surveillance System) who resided in the Health Center S&#x000f3;crates Flores Vivas (HCSFV) catchment area were visited at their homes. The HCSFV catchment area consists of 17 neighborhoods within District II of Managua, the capital city of Nicaragua. Index cases (n = 33), along with all household members willing to participate in the study (contacts, n = 109), were enrolled into this study during the first household visit (day 1). Questionnaires were administered at the first visit and at subsequent visits on days 3&#x02013;4 (visit 2), 6&#x02013;7 (visit 3), 9&#x02013;10 (visit 4), and 21 (visit 5), regardless of ZIKV infection status. The household questionnaire, addressing home-specific characteristics, was administered to the head of the household at the first home visit, and the individual questionnaire, addressing demographic, clinical history and socioeconomic status (SES)-associated factors, was administered to each household member. At each household visit, occurrence of symptoms was investigated by asking each study participant the question &#x0201c;Have you presented with any of the following symptoms?&#x0201d; followed by a list of common Zika symptoms. If a participant reported symptoms, the date of symptom onset and type of symptom(s) were recorded. During the follow-up visits (visits 2&#x02013;5), the participants were asked to report symptoms since the last visit. Hence, the symptom questionnaire should cover prior occurrence of symptoms at the first visit and symptoms since the previous visit during subsequent follow-up visits. The participants were also asked &#x0201c;Have you been diagnosed with Zika in the past?&#x0201d;, assessing previous symptomatic infections. Blood (serum or plasma), urine, and saliva samples were collected at the visits as detailed in <xref rid="pntd.0006518.t001" ref-type="table">Table 1</xref>. For the index cases that were PDCS participants (85%, n = 28), the blood collection on the second and the final study visit corresponded to a programmed PDCS visit, and plasma was collected at these two time-points (see <xref rid="pntd.0006518.t001" ref-type="table">Table 1</xref>). For saliva collection, passive drool (minimum 2 ml) was collected into vials. Laboratory testing was performed at the National Virology Laboratory (NVL) of the Ministry of Health in Managua. All household visits were performed between August 31 and October 21 of 2016, which corresponded to the tail end of the national Zika epidemic in 2016.</p><table-wrap id="pntd.0006518.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006518.t001</object-id><label>Table 1</label><caption><title>Sample collection schedule for index cases and contacts (n = 142) among enrolled households in Managua, Nicaragua, August to October, 2016.</title></caption><alternatives><graphic id="pntd.0006518.t001g" xlink:href="pntd.0006518.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1">Visit 0<xref ref-type="table-fn" rid="t001fn001"><sup>1</sup></xref></th><th align="justify" rowspan="1" colspan="1">Visit 1<xref ref-type="table-fn" rid="t001fn002"><sup>2</sup></xref><break/>Day 1</th><th align="justify" rowspan="1" colspan="1">Visit 2<break/>Days 3/4</th><th align="justify" rowspan="1" colspan="1">Visit 3<break/>Days 6/7</th><th align="justify" rowspan="1" colspan="1">Visit 4<break/>Days 9/10</th><th align="justify" rowspan="1" colspan="1">Visit 5<break/>Day 21</th></tr></thead><tbody><tr><td align="justify" colspan="2" rowspan="1"><bold>Index cases (n = 33)</bold></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">Blood</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X<xref ref-type="table-fn" rid="t001fn003"><sup>3</sup></xref></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">X<xref ref-type="table-fn" rid="t001fn003"><sup>3</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1">Urine</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td></tr><tr><td align="justify" rowspan="1" colspan="1">Saliva</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td></tr><tr><td align="justify" colspan="2" rowspan="1"><bold>Contacts (n = 109)</bold></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">Blood</td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">X</td></tr><tr><td align="justify" rowspan="1" colspan="1">Urine</td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td></tr><tr><td align="justify" rowspan="1" colspan="1">Saliva</td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td><td align="justify" rowspan="1" colspan="1">X</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><sup>1</sup>Applies only to index cases: 28 from PDCS and 5 from national surveillance (n = 33). No urine or saliva samples were available for surveillance cases.</p></fn><fn id="t001fn002"><p><sup>2</sup>Enrollment day for index cases and contacts.</p></fn><fn id="t001fn003"><p><sup>3</sup>For the 28 index cases that were PDCS participants [<xref rid="pntd.0006518.ref032" ref-type="bibr">32</xref>], the second and final visits correspond to a plasma sample, whereas all the other collected blood samples are serum. The 5 surveillance index cases only have an enrollment (visit 1) and final (visit 5) serum sample available.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec005"><title>Definitions</title><p>A suspected Zika case, whether captured from the PDCS or from national surveillance, was defined as a patient presenting with rash and one or more of the following symptoms: conjunctivitis, arthralgia, myalgia, and/or peri-articular edema, regardless of fever. A suspected Zika case became a potential index case once a ZIKV infection was confirmed by rRT-PCR in serum, urine and/or saliva.</p><p>Among contacts, ZIKV infection was defined by rRT-PCR and/or IgM positivity. IgM positivity was based on the initial and final sample and could be negative-positive (NP), positive-positive (PP) or positive-negative (PN). A symptomatic ZIKV-positive contact had at least one of the following symptoms: rash, fever, conjunctivitis, arthralgia, myalgia, peri-articular edema and/or headache.</p><p>Days post-symptom onset were calculated as following: (sample collection date)&#x02013;(symptom onset date) + 1. Hence, day 1 post-symptom onset is equivalent to the day the symptoms initiated.</p></sec><sec id="sec006"><title>Nicaraguan Pediatric Dengue Cohort Study (PDCS)</title><p>The ongoing PDCS, which served as the parent study, was established in Managua in 2004 and follows ~3,700 2-to-14 year-old children who reside in the HCSFV catchment area. The HCSFV provides health care to all study participants. Acute-phase (days 1&#x02013;5 since symptom onset) and convalescent-phase (days 14&#x02013;21) blood, saliva, and urine samples are collected from suspected dengue, chikungunya, and Zika cases, along with clinical information. Suspected dengue or chikungunya cases are patients with fever (or feverish) and two or more of the following symptoms: headache, retroocular pain, myalgia, arthralgia, rash, positive tourniquet test and/or leukopenia. Acute-phase serum samples are tested for ZIKV, chikungunya virus (CHIKV) and dengue virus (DENV) simultaneously using a multiplex rRT-PCR assay [<xref rid="pntd.0006518.ref045" ref-type="bibr">45</xref>]. Paired acute- and convalescent-phase blood samples are evaluated for dengue, chikungunya, and Zika IgM antibodies as well as total (primarily IgG) antibodies [<xref rid="pntd.0006518.ref044" ref-type="bibr">44</xref>, <xref rid="pntd.0006518.ref046" ref-type="bibr">46</xref>&#x02013;<xref rid="pntd.0006518.ref048" ref-type="bibr">48</xref>]</p></sec><sec id="sec007"><title>Laboratory assays</title><p>All diagnostic assays were performed at the NVL. Biological specimens of index cases and contacts were transported from the HCSFV to the NVL the same day as collection or, if the patient presented to the HCSFV after normal business hours, the following day. Samples were kept at 4&#x000b0;C until transported to the NVL for processing and storage at -80&#x000b0;C.</p></sec><sec id="sec008"><title>Multiplex rRT-PCR</title><p>RNA was extracted from 140 ul of blood, 200 ul of urine, or 200 ul of saliva specimens using the QIAamp Viral RNA Mini Kit (Qiagen, Valencia, CA) and amplified using the ZCD rRT-PCR assay targeting ZIKV, DENV and CHIKV [<xref rid="pntd.0006518.ref045" ref-type="bibr">45</xref>]. Testing was performed on an ABI 7500 Fast instrument (Applied Biosystems, Foster City, CA) in 25-ul reactions of the SuperScript III Platinum One-Step qRT-PCR kit (Life Technologies, Carlsbad, CA) with 5 ul of RNA template, performed as previously described [<xref rid="pntd.0006518.ref045" ref-type="bibr">45</xref>]. Each plate was processed with negative and positive controls for ZIKV, CHIKV, and DENV. Standard curves were prepared using quantitated ssDNA (Integrated DNA Technologies) containing the target sequences for ZIKV amplification. The concentration of RNA in the eluate (expressed as log<sub>10</sub> copies/ul) was calculated from the linear regression equation for the standard curve. Viremia in log<sub>10</sub> copies/ml was then calculated while accounting for the volume used for extraction. For ZIKV quantitation, a 4-point standard curve (8.0, 6.0, 4.0, and 2.0 log<sub>10</sub> copies/&#x003bc;L of eluate) was included on every plate in duplicate. Urine samples from 9 contacts were extracted at higher volumes (1 ml instead of 200 ul) to concentrate the viral RNA. Volume variation was accounted for in the viral load (VL) calculations (<xref ref-type="supplementary-material" rid="pntd.0006518.s002">S1 Table</xref>).</p></sec><sec id="sec009"><title>IgM-capture enzyme-linked immunosorbent assay (ELISA)</title><p>An in-house single-dilution IgM-capture enzyme-linked immunosorbent assay (ELISA) [<xref rid="pntd.0006518.ref048" ref-type="bibr">48</xref>] was performed to detect ZIKV-specific IgM antibodies on paired day 1 and day 21 serum/plasma samples. This method is similar to that described for detection of DENV-specific IgM [<xref rid="pntd.0006518.ref049" ref-type="bibr">49</xref>] or CHIKV-specific IgM [<xref rid="pntd.0006518.ref050" ref-type="bibr">50</xref>] and was adapted for detection of ZIKV IgM antibodies using a ZIKV envelope (E) domain III-specific monoclonal antibody (mAb), ZKA64, kindly donated by D. Corti (Humabs Biomed SA) [<xref rid="pntd.0006518.ref051" ref-type="bibr">51</xref>]. Briefly, wells were coated with goat anti-human IgM antibody overnight and then blocked using 4% bovine serum albumin (BSA) diluted in 0.05% PBS-T (1X phosphate-buffered saline containing 0.05% Tween 20). Subsequently, antigen produced from ZIKV-infected suckling mouse brain and extracted via the sucrose-acetone method [<xref rid="pntd.0006518.ref052" ref-type="bibr">52</xref>] was added. Next, a single dilution of samples and controls (1:20) was added in duplicate, followed by anti-ZIKV mAb ZKA64 conjugated to horseradish peroxidase. After every incubation step, the wells were washed 4&#x02013;5 times with 0.05% PBS-T. In the final step, 3&#x02019;3&#x02019;-5&#x02019;5&#x02019;-tetramethylbenzidine (TMB) was used to produce a colorimetric reaction that was terminated with 12.5% sulfuric acid. The cut-off was determined as 6.6 times the average of negative controls. All of the samples with absorbance values above the cut-off were considered positive. Evaluation with an extensive panel of Zika, dengue, and negative samples yielded a sensitivity of 94.5% and specificity of 85.6% [<xref rid="pntd.0006518.ref048" ref-type="bibr">48</xref>].</p></sec><sec id="sec010"><title>Entomological visits and analysis</title><p>Households were surveyed on visit 4 to assess entomological indicators. Water containers and potential breeding sites were inspected, and larvae and pupae were collected, speciated, and enumerated by experts in collaboration with the Department of Entomology at the NVL. Adult mosquitoes were captured in the interior and exterior of the houses using Prokopack backpack aspirators [<xref rid="pntd.0006518.ref053" ref-type="bibr">53</xref>, <xref rid="pntd.0006518.ref054" ref-type="bibr">54</xref>]. Captured live adults were enumerated and grouped by sex and species (<italic>Aedes aegypti</italic>, <italic>Aedes albopictus</italic> and <italic>Culex quinquefasciatus)</italic> for each household. Female bodies were homogenized after removal of legs and wings in 600 ul RNAlater<sup>&#x000ae;</sup> solution (Sigma Aldrich) to stabilize RNA for rRT-PCR analysis, and the homogenate was frozen at -80&#x000b0;C. RNA was extracted from 200 ul of the homogenate using the QIAamp Viral RNA Mini Kit (Qiagen) and analyzed for ZIKV, DENV and CHIKV positivity by rRT-PCR (see above).</p></sec><sec id="sec011"><title>Statistical analysis</title><p>ZIKV positivity and mean VL levels, along with standard deviations (SD; error bars), were calculated and graphed in R Statistical Software V.3.4.2 [<xref rid="pntd.0006518.ref055" ref-type="bibr">55</xref>]. Duration of RNA detection was determined based on the maximum number of days duration of ZIKV RNA detection for each bodily fluid, where the days were based on symptom onset (see calculation of days post-symptom onset under the &#x0201c;Definitions&#x0201d; section above). The sample size for each time-point (listed by bodily fluid in table below graph) was based on days post-symptom onset. Several time-points had few samples due to variation of days post-symptom onset at which the participants were enrolled. The first time-point of 5 surveillance index cases and 4 ZIKV rRT-PCR-positive contacts with no symptoms were excluded from the ZIKV positivity and VL analysis due to missing VL data and day of symptom onset information, respectively. Further, an extreme outlier for urine VL was excluded (8 days post-symptom onset, 8.9 log<sub>10</sub> copies/ml). Percent positivity was defined as the percent of positive samples at specified days post-symptom onset for each bodily fluid.</p><p>The symptomatic infection rate attributable to ZIKV infection for the contacts (n = 109) was calculated by subtracting the percent of ZIKV-negative contacts with ZIKV-associated symptoms (12/72 = 17%) from the percent of ZIKV-positive contacts with ZIKV-associated symptoms (14/37 = 38%) [<xref rid="pntd.0006518.ref043" ref-type="bibr">43</xref>]. Risk ratios (RR) were calculated using modified Poisson regression [<xref rid="pntd.0006518.ref056" ref-type="bibr">56</xref>] in the context of a general estimating equations (GEE) model to identify associations between risk factors and contacts being positive for ZIKV infection by either rRT-PCR and/or IgM ELISA. The GEE model accounts for clustering due to the household-based study design. An exchangeable correlation structure was assumed, and confidence intervals were calculated using a robust (sandwich) variance estimator. The following were considered risk factors of interest for ZIKV infection: sex, age, household size, water faucet location outside of the house, on-site water storage, and recognizing mosquito larvae or pupae (all binary). Lack of variation in the study population precluded meaningful analysis of fumigation, abatement use, trash collection services, water services and repellent use reports. Potential confounders were assessed based on a literature-informed directed acyclic graph (DAG; <xref ref-type="supplementary-material" rid="pntd.0006518.s001">S1 Fig</xref>). Due to the small sample size and minimal variation of the confounders among participants, the multivariate analysis was adjusted for a single SES proxy indicator; namely owning a refrigerator. All analyses were conducted using SAS version 9.4 (SAS Institute, Cary NC). The map was constructed in ArcGIS ArcMap V.10.3 (Environmental Systems Research Institute, Redlands CA).</p></sec></sec><sec sec-type="results" id="sec012"><title>Results</title><sec id="sec013"><title>Identification and spatial distribution of index cases and contacts</title><p>A total of 33 symptomatic rRT-PCR ZIKV-positive index cases were enrolled between August 31 and October 21 of 2016 (<xref ref-type="fig" rid="pntd.0006518.g001">Fig 1</xref>). Each index case represented one household located within the HCSFV catchment area, which includes 17 neighborhoods in District II of Managua (<xref ref-type="fig" rid="pntd.0006518.g002">Fig 2</xref>). The majority of the index cases (85%, n = 28) were participants of the Nicaraguan PDCS [<xref rid="pntd.0006518.ref044" ref-type="bibr">44</xref>]. The remaining 5 index cases were captured as part of the national surveillance system; of these, 4 were pregnant women. The Ministry of Health prioritized Zika diagnosis for pregnant women upon symptom onset due to the known congenital risk factors. A total of 109 contacts, including two pregnant women, were enrolled at the first household visit from the 33 households, corresponding to a total of 142 participants. While all subjects approached agreed to participate in the study and there was no loss to follow-up, a total of 85 household members (37%) who were reported to be living in the respective home by the head of the household, but were not at home during the enrollment visit, were not interviewed or enrolled (<xref ref-type="supplementary-material" rid="pntd.0006518.s003">S2 Table</xref>). One enrolled contact did not answer the individual questionnaire but fulfilled the other study requirements, including the symptom questionnaire and sample donation. The number of enrolled contacts per household ranged from 1 to 7, with an average of 3.3 &#x000b1; SD of 1.6. The average age of index cases and contacts was 11.4 (&#x000b1;7.8, range 2&#x02013;37) and 30.7 (&#x000b1;20.6, range 1&#x02013;79) years, respectively (<xref rid="pntd.0006518.t002" ref-type="table">Table 2</xref>). The index cases tended to be younger since the majority were PDCS participants. Both index cases and contacts were 70% female. The heads of the 33 enrolled households reported little variation with respect to SES-associated household characteristics: 100% reported zinc as the roof material; 100% reported to be the house owners; 97% (n = 32) reported the house floor material to be concrete, brick, and/or ceramic tiles, and only one reported a dirt floor; none reported owning an air conditioner; and 67% (n = 22) reported owning a refrigerator.</p><fig id="pntd.0006518.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006518.g001</object-id><label>Fig 1</label><caption><title>Flow chart of study design and enrollment for index cluster study of ZIKV infection in Managua, Nicaragua, 2016.</title><p>*One enrolled contact did not answer the individual questionnaire but fulfilled the other study requirements such as symptom questionnaire and sample donation.</p></caption><graphic xlink:href="pntd.0006518.g001"/></fig><fig id="pntd.0006518.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006518.g002</object-id><label>Fig 2</label><caption><title>Geographic distribution of enrolled households, based on ZIKV-positive index cases from the Health Center S&#x000f3;crates Flores Vivas, Managua, Nicaragua, August to October, 2016.</title></caption><graphic xlink:href="pntd.0006518.g002"/></fig><table-wrap id="pntd.0006518.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006518.t002</object-id><label>Table 2</label><caption><title>Demographic characteristics, ZIKV infection and symptomatic Zika status among study participants in Managua, Nicaragua, August to October, 2016.</title></caption><alternatives><graphic id="pntd.0006518.t002g" xlink:href="pntd.0006518.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">Characteristics</th><th align="left" rowspan="1" colspan="1">Index cases (n = 33)<break/>n (%)</th><th align="left" rowspan="1" colspan="1">Contacts (n = 109)<break/>n (%)</th><th align="left" rowspan="1" colspan="1">At enrollment ZIKV IgM+ (n = 23)<break/>n (%)<xref ref-type="table-fn" rid="t002fn001"><sup>1</sup></xref></th><th align="left" rowspan="1" colspan="1">At enrollment ZIKV rRT-PCR+ (n = 11)<break/>n (%)<xref ref-type="table-fn" rid="t002fn002"><sup>2</sup></xref></th><th align="left" rowspan="1" colspan="1">Incident cases (n = 3)<break/>n (%)<xref ref-type="table-fn" rid="t002fn003"><sup>3</sup></xref></th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">Age (years)</td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">&#x0003c; 15</td><td align="justify" rowspan="1" colspan="1">28 (85)</td><td align="justify" rowspan="1" colspan="1">29 (27)</td><td align="justify" rowspan="1" colspan="1">6 (26)</td><td align="justify" rowspan="1" colspan="1">6 (55)</td><td align="justify" rowspan="1" colspan="1">1 (33)</td></tr><tr><td align="justify" rowspan="1" colspan="1">&#x02265; 15</td><td align="justify" rowspan="1" colspan="1">5 (15)</td><td align="justify" rowspan="1" colspan="1">80 (73)</td><td align="justify" rowspan="1" colspan="1">17 (74)</td><td align="justify" rowspan="1" colspan="1">5 (45)</td><td align="justify" rowspan="1" colspan="1">2 (67)</td></tr><tr><td align="justify" rowspan="1" colspan="1">Mean</td><td align="justify" rowspan="1" colspan="1">11.4</td><td align="justify" rowspan="1" colspan="1">30.7</td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">Gender</td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">Male</td><td align="justify" rowspan="1" colspan="1">10 (30)</td><td align="justify" rowspan="1" colspan="1">33 (30)</td><td align="justify" rowspan="1" colspan="1">7 (30)</td><td align="justify" rowspan="1" colspan="1">3 (27)</td><td align="justify" rowspan="1" colspan="1">2 (67)</td></tr><tr><td align="justify" rowspan="1" colspan="1">Female</td><td align="justify" rowspan="1" colspan="1">23 (70)</td><td align="justify" rowspan="1" colspan="1">76 (70)</td><td align="justify" rowspan="1" colspan="1">16 (70)</td><td align="justify" rowspan="1" colspan="1">8 (73)</td><td align="justify" rowspan="1" colspan="1">1 (33)</td></tr><tr><td align="justify" colspan="3" rowspan="1">Symptoms in ZIKV-positive contacts<xref ref-type="table-fn" rid="t002fn004"><sup>4</sup></xref></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">Yes</td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">6 (26)</td><td align="justify" rowspan="1" colspan="1">7 (64)</td><td align="justify" rowspan="1" colspan="1">1 (33)</td></tr><tr><td align="justify" rowspan="1" colspan="1">No</td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">17 (74)</td><td align="justify" rowspan="1" colspan="1">4 (36)</td><td align="justify" rowspan="1" colspan="1">2 (67)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p><sup>1</sup> Zika IgM-positive contacts at enrollment = single Zika IgM-positive result at visit 1.</p></fn><fn id="t002fn002"><p><sup>2</sup>ZIKV rRT-PCR-positive contacts at enrollment (7 by PCR only and 4 by both rRT-PCR and IgM).</p></fn><fn id="t002fn003"><p><sup>3</sup>Three post-enrollment ZIKV infections, hence incident cases, among contacts were captured by IgM conversion, but all collected bodily fluid samples remained rRT-PCR-negative throughout.</p></fn><fn id="t002fn004"><p><sup>4</sup>Symptoms for ZIKV-positive contacts (n = 37) by assay (IgM or rRT-PCR) and time-point (at or post-enrollment). All enrolled ZIKV rRT-PCR confirmed index cases (n = 33) were symptomatic.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec014"><title>ZIKV infection and transmission</title><p>Serum/plasma, urine, and saliva samples were collected from index cases and contacts during a total of 165 household visits (5 visits to 33 households, see <xref rid="pntd.0006518.t001" ref-type="table">Table 1</xref>) and analyzed by molecular and serological assays as described in the Methods section. At enrollment, 34 contacts (31%) were positive for ZIKV infection, of which 11 (32%) were acutely infected (<xref rid="pntd.0006518.t002" ref-type="table">Table 2</xref>; 7 rRT-PCR-positive only and 4 rRT-PCR- and IgM-positive). The remaining 23 (68%) were positive by IgM only, indicating a recent ZIKV infection. The majority of the cases that were ZIKV-positive at enrollment were 15 years or older (n = 22, 65%) and female (n = 24, 71%). Three ZIKV incident infections were captured by IgM seroconversion among the contacts who were initially Zika-na&#x000ef;ve, two of whom were 15 years or older and one female. The three seroconversions were located in different households. Overall, a total of 37 (34%) positive contacts were identified during the study period, 34 at enrollment and 3 post-enrollment, corresponding to 20 households. Hence, 20 households (61%) recorded ZIKV-infected contacts, with an average of 1.9 positives per household (&#x000b1;1.4, range: 1&#x02013;6) among enrolled household members (<xref rid="pntd.0006518.t003" ref-type="table">Table 3</xref>, <xref ref-type="supplementary-material" rid="pntd.0006518.s003">S2 Table</xref>). The corresponding ZIKV positivity per household ranged from 17% to 100%, with an average of 53% (&#x000b1;26.4), and in 60% of these households, &#x02265;50% of the members tested were ZIKV-positive (<xref rid="pntd.0006518.t003" ref-type="table">Table 3</xref>, <xref ref-type="supplementary-material" rid="pntd.0006518.s003">S2 Table</xref>). CHIKV and DENV rRT-PCR was performed on each sample analyzed, as part of the rRT-PCR multiplex assay, but no positive results were obtained.</p><table-wrap id="pntd.0006518.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006518.t003</object-id><label>Table 3</label><caption><title>ZIKV infection positivity and percent symptomatic contacts among enrolled households in Managua, Nicaragua, August to October, 2016.</title></caption><alternatives><graphic id="pntd.0006518.t003g" xlink:href="pntd.0006518.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">#</th><th align="left" rowspan="1" colspan="1">House</th><th align="left" rowspan="1" colspan="1">Pos. Contacts<xref ref-type="table-fn" rid="t003fn001"><sup>1</sup></xref></th><th align="left" rowspan="1" colspan="1">Total Contacts</th><th align="left" rowspan="1" colspan="1">% Positivity</th><th align="left" rowspan="1" colspan="1">Sympt. Pos. Contacts<xref ref-type="table-fn" rid="t003fn002"><sup>2</sup></xref></th><th align="left" rowspan="1" colspan="1">% Sympto-matic<xref ref-type="table-fn" rid="t003fn003"><sup>3</sup></xref></th><th align="left" rowspan="1" colspan="1">Incident cases</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">6</td><td align="justify" rowspan="1" colspan="1">17</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">14</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">4</td><td align="justify" rowspan="1" colspan="1">25</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">18</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">4</td><td align="justify" rowspan="1" colspan="1">25</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">4</td><td align="justify" rowspan="1" colspan="1">20</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">4</td><td align="justify" rowspan="1" colspan="1">25</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">5</td><td align="justify" rowspan="1" colspan="1">31</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">4</td><td align="justify" rowspan="1" colspan="1">25</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">6</td><td align="justify" rowspan="1" colspan="1">9</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">33</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1">X</td></tr><tr><td align="justify" rowspan="1" colspan="1">7</td><td align="justify" rowspan="1" colspan="1">16</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">33</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">8</td><td align="justify" rowspan="1" colspan="1">33</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">33</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">9</td><td align="justify" rowspan="1" colspan="1">7</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">50</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">10</td><td align="justify" rowspan="1" colspan="1">17</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">50</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1">X</td></tr><tr><td align="justify" rowspan="1" colspan="1">11</td><td align="justify" rowspan="1" colspan="1">26</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">50</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">12</td><td align="justify" rowspan="1" colspan="1">11</td><td align="justify" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">6</td><td align="justify" rowspan="1" colspan="1">50</td><td align="justify" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">13</td><td align="justify" rowspan="1" colspan="1">19</td><td align="justify" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">6</td><td align="justify" rowspan="1" colspan="1">50</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">33</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">14</td><td align="justify" rowspan="1" colspan="1">5</td><td align="justify" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">67</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">50</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">15</td><td align="justify" rowspan="1" colspan="1">12</td><td align="justify" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">67</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">50</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">16</td><td align="justify" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">4</td><td align="justify" rowspan="1" colspan="1">6</td><td align="justify" rowspan="1" colspan="1">67</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">25</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">17</td><td align="justify" rowspan="1" colspan="1">30</td><td align="justify" rowspan="1" colspan="1">6</td><td align="justify" rowspan="1" colspan="1">7</td><td align="justify" rowspan="1" colspan="1">86</td><td align="justify" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">33</td><td align="justify" rowspan="1" colspan="1">X</td></tr><tr><td align="justify" rowspan="1" colspan="1">18</td><td align="justify" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">19</td><td align="justify" rowspan="1" colspan="1">23</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">20</td><td align="justify" rowspan="1" colspan="1">32</td><td align="justify" rowspan="1" colspan="1">4</td><td align="justify" rowspan="1" colspan="1">4</td><td align="justify" rowspan="1" colspan="1">100</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1">0</td><td align="justify" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p><sup>1</sup> ZIKV-positive contacts: laboratory-confirmed by ZIKV RT-PCR and/or IgM ELISA.</p></fn><fn id="t003fn002"><p><sup>2</sup>Symptomatic ZIKV-positive contacts: laboratory-confirmed ZIKV RT-PCR- and/or IgM-positive contacts that reported ZIKV-associated symptoms.</p></fn><fn id="t003fn003"><p><sup>3</sup> Percent of symptomatic cases among ZIKV-positive contacts in each household.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec015"><title>Detectable ZIKV RNA in bodily fluids</title><p>Despite the modest number of rRT-PCR confirmed ZIKV infections captured (33 index cases and 11 contacts), a total of 522 bodily fluid samples were processed by rRT-PCR (105 serum/plasma, 206 saliva, and 212 urine, <xref ref-type="fig" rid="pntd.0006518.g003">Fig 3</xref> and <xref ref-type="supplementary-material" rid="pntd.0006518.s002">S1</xref> and <xref ref-type="supplementary-material" rid="pntd.0006518.s004">S3</xref> Tables). All 44 rRT-PCR-confirmed ZIKV infections were positive at the entry visit: 13 (29%) were positive for ZIKV RNA in urine and saliva; 11 (25%) were positive in serum and saliva; 10 (23%) in serum only; 5 (11%) in urine only; 2 (5%) in serum, saliva and urine; 2 (5%) in saliva only; and 1 (2%) in serum and urine. Percent positivity (see <xref ref-type="sec" rid="sec002">Methods</xref>) declined over time for all fluids (<xref ref-type="fig" rid="pntd.0006518.g003">Fig 3</xref>), with the exception of several time-points where the sample size was very small (numbers presented in the table at the bottom of <xref ref-type="fig" rid="pntd.0006518.g003">Fig 3</xref> are total number of specimens processed). Among rRT-PCR-positive subjects with Zika-associated symptoms, the maximum number of days duration of ZIKV RNA detection was 7 days post-symptom onset in serum/plasma and saliva and 22 days in urine (<xref ref-type="fig" rid="pntd.0006518.g003">Fig 3</xref>). The mean number of days duration of ZIKV RNA detection was 2.56 (SD: 1.53), 3.10 (SD: 1.50) and 5.94 (SD: 3.80) days post-symptom onset in serum/plasma, saliva and urine, respectively (<xref ref-type="supplementary-material" rid="pntd.0006518.s004">S3 Table</xref>).</p><fig id="pntd.0006518.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006518.g003</object-id><label>Fig 3</label><caption><title>ZIKV rRT-PCR positivity in bodily fluid samples by day post-symptom onset, collected in enrolled households in Managua, August to October, 2016.</title><p>The graph depicts ZIKV rRT-PCR positivity (%) in serum/plasma, saliva and urine over days post-symptom onset. The numbers presented in the table at the bottom are the total number of specimens processed for each bodily fluid at each time-point.</p></caption><graphic xlink:href="pntd.0006518.g003"/></fig><p>Overall, VL tended to decrease over time, and mean VL in the serum/plasma, saliva, and urine specimens was comparable, with 5.6 (&#x000b1; 1.2, range 2.9&#x02013;8.1), 5.3 (&#x000b1; 0.8, range 3.2&#x02013;6.9) and 4.5 (&#x000b1; 1.0, range 1.7&#x02013;6.6) log<sub>10</sub> copies/ml, respectively, with serum attaining the highest VL peak at 8.1 log<sub>10</sub> copies/ml (<xref ref-type="fig" rid="pntd.0006518.g004">Fig 4</xref>). Interestingly, one contact had a serum VL of 6.7 log<sub>10</sub> copies/ml two days before symptom onset (data point excluded from <xref ref-type="fig" rid="pntd.0006518.g004">Fig 4</xref>). Previous reports suggest prolonged maternal viremia in pregnant women [<xref rid="pntd.0006518.ref057" ref-type="bibr">57</xref>&#x02013;<xref rid="pntd.0006518.ref060" ref-type="bibr">60</xref>]. While our sample size was very small, the four ZIKV rRT-PCR confirmed pregnant women in our study had a mean VL of 4.4 log<sub>10</sub> copies/ml ZIKV in urine (up to 7 days post-symptom onset) and mean VL of 3.5 log<sub>10</sub> copies/ml in serum/plasma (up to 5 days), comparable to non-pregnant subjects; however, the women were only followed for 21 days.</p><fig id="pntd.0006518.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006518.g004</object-id><label>Fig 4</label><caption><title>ZIKV viral load kinetics over time in bodily fluid samples (serum/plasma, saliva and urine) by day post-symptom onset, collected in enrolled households in Managua, August to October, 2016.</title><p>Mean and standard deviation of viral load in bodily fluids plotted according to day post-symptom onset.</p></caption><graphic xlink:href="pntd.0006518.g004"/></fig></sec><sec id="sec016"><title>Symptomatic to asymptomatic (S:A) ratio</title><p>On average, the symptomatic index and contact cases (n = 40) were enrolled 2.2 days post-symptom onset (&#x000b1;1.5, range -1 to 7). Among the 37 Zika-positive contacts, 14 were symptomatic (38%), while 12 of 72 ZIKV-negative contacts reported similar symptoms (17%), resulting in a 21% symptomatic infection rate attributable to ZIKV infection (see <xref ref-type="sec" rid="sec002">Methods</xref>). Among the 14 symptomatic Zika-positive contacts (7 rRT-PCR and 7 IgM-positive, see <xref rid="pntd.0006518.t002" ref-type="table">Table 2</xref>), the following Zika-associated symptoms were recorded: rash (57%), arthralgia (43%), fever (36%) and headache (29%). While conjunctivitis was listed on the symptom questionnaire, it was not reported by any of the Zika cases. These results are consistent with the parent PDCS cohort, where only 6% of Zika cases reported conjunctivitis during the epidemic. Several other symptoms, such as cough, shivers, difficulty breathing, ophthalmoplegia, nausea, and pruritus were reported (<xref ref-type="supplementary-material" rid="pntd.0006518.s005">S4 Table</xref>). Furthermore, a symptomatic to asymptomatic (S:A) ratio of 14:23 (1:1.6) was determined among the contacts. Of the 23 asymptomatic ZIKV-positive contacts, 4 were rRT-PCR- and IgM-positive, and 19 were positive by serology only (<xref rid="pntd.0006518.t002" ref-type="table">Table 2</xref>). Of the 20 households with ZIKV-positive contacts, 11 (55%) contained symptomatic contacts (<xref rid="pntd.0006518.t003" ref-type="table">Table 3</xref>). The percent of symptomatic cases among ZIKV-positive contacts in the households ranged from 25&#x02013;100%, with an average of 40% (&#x000b1; 43.8).</p></sec><sec id="sec017"><title>Entomological analysis</title><p>An entomological survey was completed for each household during visit 4. Twenty-three (70%) of the inspected households were positive for adult mosquitoes, and a total of 109 specimens were captured. Of these, 85 (78%) were identified as <italic>Aedes (Ae</italic>.<italic>) aegypti</italic> and 24 (22%) as <italic>Culex quinquefasciatus</italic>. All 41 of the captured female <italic>Ae</italic>. <italic>aegypti</italic> tested negative for ZIKV, CHIKV, and DENV RNA by rRT-PCR. Seven (21%) of the inspected households were positive for <italic>Ae</italic>. <italic>aegypti</italic> larvae and/or pupae (total of 615 identified specimens). The majority of households (52%, n = 17) had ZIKV-infected residents as well as <italic>Ae</italic>. <italic>aegypti</italic> mosquitoes and/or infested water containers on the premises, whereas only 3 households (9%) had Zika-positive residents and were found to be free of <italic>Ae</italic>. <italic>aegypti</italic> mosquitoes and pupae/larvae. The remaining households were either mosquito/larvae/pupae-positive and Zika-negative (24%, n = 8) or mosquito/larvae/pupae-negative and Zika-negative (15%, n = 5).</p></sec><sec id="sec018"><title>Risk factor analysis for ZIKV infection</title><p>All households reported abatement of water containers with Temephos in and around the household. A total of 29 (88%) households reported Temephos being deposited four times per year (abatement), and all households reported fumigation. The Ministry of Health provided these vector control measures at no cost. All households reported regular trash collection service, and only 12% (n = 4) reported having problems with regular water supply, thus precluding meaningful analysis. Repellent use was rare, with only 8% (n = 9) reporting use; 5 female and 4 male. Sex, age (being &#x02265;15 years old), household size (&#x02265;4 contacts in a household), having a water faucet located outside of the house, and recognizing mosquito larvae or pupae were not statistically associated with ZIKV infection (<xref rid="pntd.0006518.t004" ref-type="table">Table 4</xref>). The risk of being ZIKV-positive among those who reported storing water on site, adjusted for owning a refrigerator (SES indicator), was 2.32 (95%CI: 1.26, 4.28) times the risk of being ZIKV-positive among those who reported not storing water, across households.</p><table-wrap id="pntd.0006518.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006518.t004</object-id><label>Table 4</label><caption><title>Risk factor analysis for ZIKV infection among contacts (n = 109).</title></caption><alternatives><graphic id="pntd.0006518.t004g" xlink:href="pntd.0006518.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Risk Factor (binary)</th><th align="left" rowspan="1" colspan="1">N (%)</th><th align="left" rowspan="1" colspan="1">RR (95% CI)<xref ref-type="table-fn" rid="t004fn002"><sup>1</sup></xref></th><th align="left" rowspan="1" colspan="1">aRR (95% CI)<xref ref-type="table-fn" rid="t004fn003"><sup>2</sup></xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">76 (70)</td><td align="left" rowspan="1" colspan="1">0.79 (0.50, 1.24)</td><td align="left" rowspan="1" colspan="1">0.80 (0.51, 1.26)</td></tr><tr><td align="left" rowspan="1" colspan="1">Age, &#x02265;15 yrs</td><td align="left" rowspan="1" colspan="1">80 (73)</td><td align="left" rowspan="1" colspan="1">0.70 (0.42, 1.16)</td><td align="left" rowspan="1" colspan="1">0.68 (0.41, 1.13)</td></tr><tr><td align="left" rowspan="1" colspan="1">Contacts &#x02265; 4<xref ref-type="table-fn" rid="t004fn004"><sup>3</sup></xref></td><td align="left" rowspan="1" colspan="1">60 (55)</td><td align="center" rowspan="1" colspan="1">1.61 (0.84, 3.09)</td><td align="center" rowspan="1" colspan="1">1.60 (0.83, 3.06)</td></tr><tr><td align="left" rowspan="1" colspan="1">Owning refrigerator</td><td align="left" rowspan="1" colspan="1">79 (73)</td><td align="center" rowspan="1" colspan="1">1.15 (0.59, 2.25)</td><td align="center" rowspan="1" colspan="1">NA<xref ref-type="table-fn" rid="t004fn005"><sup>4</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">On-site water storage</td><td align="left" rowspan="1" colspan="1">35 (32)</td><td align="center" rowspan="1" colspan="1"><bold>2.27 (1.24, 4.16)</bold></td><td align="center" rowspan="1" colspan="1"><bold>2.32 (1.26, 4.28)</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Outside faucet location</td><td align="left" rowspan="1" colspan="1">64 (59)</td><td align="left" rowspan="1" colspan="1">0.74 (0.38, 1.45)</td><td align="left" rowspan="1" colspan="1">0.74 (0.38, 1.47)</td></tr><tr><td align="left" rowspan="1" colspan="1">Recognizing larvae/pupae</td><td align="left" rowspan="1" colspan="1">67 (62)</td><td align="left" rowspan="1" colspan="1">0.85 (0.43, 1.66)</td><td align="left" rowspan="1" colspan="1">0.85 (0.43, 1.66)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>Note: Bold indicates significance at p&#x0003c;0.05</p></fn><fn id="t004fn002"><p><sup>1</sup>Risk Ratio and 95% Confidence Interval, across households.</p></fn><fn id="t004fn003"><p><sup>2</sup>Risk Ratio adjusted for owning refrigerator (SES indicator) and 95% Confidence Interval, across households.</p></fn><fn id="t004fn004"><p><sup>3</sup>Contacts living in a household with 4 or more contacts.</p></fn><fn id="t004fn005"><p><sup>4</sup>Not applicable.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="conclusions" id="sec019"><title>Discussion</title><p>This investigation of ZIKV household transmission enabled determination of the S:A ratio, duration of detectable ZIKV RNA, kinetics of ZIKV VL in bodily fluids, and risk factors for ZIKV infection. The index cluster study design enables capture of asymptomatic infections, since symptom data are actively sought, in this case approximately every 3&#x02013;4 days for the first 9&#x02013;10 days and then again 11&#x02013;12 days later. We calculated an S:A ratio of 1:1.6, corresponding to 62% asymptomatic ZIKV infections, which is consistent with published studies [<xref rid="pntd.0006518.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pntd.0006518.ref038" ref-type="bibr">38</xref>]. Previous reports found the percent of asymptomatic ZIKV infections to range from 27% (by systematically screening returning travelers from Suriname) [<xref rid="pntd.0006518.ref036" ref-type="bibr">36</xref>] to 82% (based on a household serological survey during the Yap Island Zika outbreak, where 18% of Zika IgM-positive individuals reported symptoms likely attributable to ZIKV infection [<xref rid="pntd.0006518.ref034" ref-type="bibr">34</xref>]). These findings, along with our detection of relatively high serum VL before symptom onset, imply that asymptomatic infection is an important factor in ZIKV transmission. Further, our study found that 61% of the households had contacts with ZIKV infection, with an average of 1.9 (range 1&#x02013;6) positive contacts per household. In 60% of the households, &#x02265;50% of the members were positive for ZIKV infection. Thus, the majority of the households and the majority of household members of the ZIKV-positive index cases were positive for ZIKV infection, suggesting that ZIKV transmission was widespread among the enrolled households in urban Managua, Nicaragua.</p><p>Analysis of the magnitude of ZIKV VL in different bodily fluids revealed overall similar VL values in serum/plasma, saliva, and urine specimens, with serum attaining the highest peak VL (8.1 log<sub>10</sub> copies/ml), similar to previously reported ZIKV VL levels [<xref rid="pntd.0006518.ref037" ref-type="bibr">37</xref>]. ZIKV RNA was detected in all three bodily fluids from the first day of symptom onset, while VL decreased over time. Interestingly, one contact had relatively high serum VL (6.7 log<sub>10</sub> copies/ml) two days before symptom onset. This is consistent with the previously estimated incubation period of 3&#x02013;14 days [<xref rid="pntd.0006518.ref061" ref-type="bibr">61</xref>], and viremia prior to symptom onset has been reported in blood donors (1&#x02013;6 days) in Martinique [<xref rid="pntd.0006518.ref037" ref-type="bibr">37</xref>]. As for duration, our data revealed detectable viral RNA up to 7 days post-symptom onset in serum/plasma and saliva and up to 22 days in urine. Hence, ZIKV was present the longest in urine, consistent with other publications [<xref rid="pntd.0006518.ref025" ref-type="bibr">25</xref>, <xref rid="pntd.0006518.ref026" ref-type="bibr">26</xref>, <xref rid="pntd.0006518.ref029" ref-type="bibr">29</xref>, <xref rid="pntd.0006518.ref033" ref-type="bibr">33</xref>]. While reported duration of ZIKV RNA detection in bodily fluids varies greatly, studies have found detection times up to 29 days post-symptom onset in saliva and urine and up to 14 days in serum [<xref rid="pntd.0006518.ref002" ref-type="bibr">2</xref>, <xref rid="pntd.0006518.ref021" ref-type="bibr">21</xref>, <xref rid="pntd.0006518.ref022" ref-type="bibr">22</xref>, <xref rid="pntd.0006518.ref024" ref-type="bibr">24</xref>&#x02013;<xref rid="pntd.0006518.ref032" ref-type="bibr">32</xref>]. Given that all captured index cases were symptomatic and that 33 of the 44 rRT-PCR-positive cases were index cases, it is possible that infection rates and viral loads detected differ from studies conducted among asymptomatic cases, such as viremic blood donors.</p><p>In our analysis, all index cases that had initial saliva samples (n = 26) would have been captured as ZIKV rRT-PCR-positive with acute saliva samples only. Furthermore, saliva and serum/plasma had similar mean VL levels and mean days of ZIKV detection. Other studies detected ZIKV RNA more frequently in saliva than in serum samples, while the mean number of days duration from symptom onset was the same (3.5 days) [<xref rid="pntd.0006518.ref030" ref-type="bibr">30</xref>, <xref rid="pntd.0006518.ref032" ref-type="bibr">32</xref>]. Another study found that while no cases were exclusively positive in saliva, when screening serum, whole blood, urine and saliva, testing saliva instead of urine or saliva did not lower the diagnostic sensitivity during acute infection [<xref rid="pntd.0006518.ref024" ref-type="bibr">24</xref>]. Hence, saliva, an accessible and non-invasive sample, may be an underrated and feasible diagnostic specimen for ZIKV rRT-PCR testing in suspected symptomatic cases, although it does not extend the window of detection beyond that of serum or whole blood [<xref rid="pntd.0006518.ref033" ref-type="bibr">33</xref>].</p><p>It is known that water storage containers, present mostly due to intermittent water supply, create mosquito breeding sites and thus increase risk of virus transmission [<xref rid="pntd.0006518.ref062" ref-type="bibr">62</xref>]. Entomological visits conducted on Yap Island during the Zika outbreak in 2007 found that 87% of the surveyed households had larvae- or pupae-infested water containers, although no viral RNA was detected in mosquitoes and/or immature stages [<xref rid="pntd.0006518.ref034" ref-type="bibr">34</xref>]. In our study, 21% of the inspected households had water containers infested with <italic>Ae</italic>. <italic>aegypti</italic> larvae or pupae. As for adult mosquitoes, 70% of the households were positive, but none of the adult female <italic>Ae</italic>. <italic>aegypti</italic> captured during the entomological visits were positive for ZIKV RNA. However, these results could have been affected by the intensive government vector control activities (fumigation and abatement) implemented concurrently with the study. Although analysis of Zika-positive households and entomological indicators revealed no significant associations, 52% of the households were positive for both ZIKV-infected residents and the presence of mosquitoes, larvae and/or pupae.</p><p>A major strength of the study was the number of visits per household&#x02013; 5 visits in a time span of 21 days&#x02014;that enabled close monitoring of the duration of ZIKV RNA detection and symptoms. The study also experienced several limitations. The Nicaraguan Zika epidemic lasted from June to October of 2016, with peak incidence in July and August. Hence, the present study was conducted during the tail end of the epidemic, which is likely the reason that few transmission events were captured. Because of the antigenic relatedness of flaviviruses, particularly DENV and ZIKV, the IgM ELISA can potentially display cross-reactivity between ZIKV- and DENV-induced antibodies. However, comprehensive evaluation of the in-house MAC-ELISA with an extensive panel of specimens yielded a sensitivity of 94.5% and specificity of 85.6% when compared to rRT-PCR-confirmed Zika or dengue cases and flavivirus-na&#x000ef;ve individuals, respectively. While specificity could not be analyzed in this study, the in-house IgM ELISA captured all rRT-PCR-confirmed index cases, indicating excellent sensitivity. Furthermore, no DENV infections were detected by rRT-PCR in this study and the concurrent parent cohort study, suggesting that potential false-positive Zika IgM results due to cross-reactivity were unlikely. Finally, symptomatic Zika cases may have been erroneously categorized as asymptomatic, due to recall bias. However, as a whole, the questionnaires were likely to capture previous Zika-associated symptoms since: (i) of 23 cases that were ZIKV-positive at enrollment, 6 (rRT-PCR-negative IgM-positive) did report Zika-related symptoms; (ii) symptoms such as arthralgia may be persistent and re-occurring [<xref rid="pntd.0006518.ref032" ref-type="bibr">32</xref>]; (iii) the participants were asked to report previously diagnosed ZIKV infections, likely capturing previous Zika-associated symptoms; and (iv) the 62% of asymptomatic infections are well within the previously reported range.</p><p>In conclusion, our ZIKV household study found that the majority of homes had &#x02265;50% of Zika-positive members, demonstrating that ZIKV transmission was widespread among the enrolled households in urban Managua. Further, an S:A ratio of 14:23 (1:1.6) was estimated among the contacts, indicating that 62% of the infections were asymptomatic, thus contributing to silent transmission. Finally, the maximum number of days during which ZIKV RNA was detected was 7 days post-symptom onset in saliva and serum/plasma and 22 days in urine. Detecting ZIKV in saliva over a similar time period and concentration as serum/plasma indicates that saliva could potentially serve as a more accessible diagnostic sample. These findings provide information about detection of viral RNA, thus informing strategies for ZIKV detection in bodily fluids. The study also estimated urban ZIKV dissemination along with percent asymptomatic infections, assessing likelihood of silent transmission. Overall, the findings presented inform public health decision-making about Zika interventions, diagnostic methods and strategies, and vector control activities in Nicaragua, the region and globally.</p></sec><sec sec-type="supplementary-material" id="sec020"><title>Supporting information</title><supplementary-material content-type="local-data" id="pntd.0006518.s001"><label>S1 Fig</label><caption><title>Directed acyclic graph (DAG) visualizing the causal assumptions for ZIKV infection risk factor analysis.</title><p>Outcome was ZIKV infection and risk factors of interest were the following: sex, age, household size, water faucet location outside of the house, on-site water storage, recognizing mosquito larvae or pupae, fumigation, abatement use, trash collection services, water services and repellent use reports. SES; socioeconomic status. U; unknown.</p><p>(PDF)</p></caption><media xlink:href="pntd.0006518.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006518.s002"><label>S1 Table</label><caption><title>Zika virus (ZIKV)-positive index cases and contacts as determined by rRT-PCR in bodily fluids over study visits.</title><p>(PDF)</p></caption><media xlink:href="pntd.0006518.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006518.s003"><label>S2 Table</label><caption><title>Total reported and enrolled household members among the study households (n = 33).</title><p>(PDF)</p></caption><media xlink:href="pntd.0006518.s003.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006518.s004"><label>S3 Table</label><caption><title>Duration of ZIKV RNA detection in bodily fluids of ZIKV rRT-PCR-positive study participants who presented Zika-associated symptoms.</title><p>(PDF)</p></caption><media xlink:href="pntd.0006518.s004.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006518.s005"><label>S4 Table</label><caption><title>Symptoms recorded for study participants and ZIKV status based on rRT-PCR and/or IgM laboratory results.</title><p>(PDF)</p></caption><media xlink:href="pntd.0006518.s005.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006518.s006"><label>S1 Checklist</label><caption><title>STROBE checklist.</title><p>(PDF)</p></caption><media xlink:href="pntd.0006518.s006.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The study team would like to thank Dr. Lionel Gresh and Dr. Leah C. Katzelnick for helpful discussion and insight and Anna Gajewski for her assistance with the IRB application.</p></ack><ref-list><title>References</title><ref id="pntd.0006518.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Zanluca</surname><given-names>C</given-names></name>, <name><surname>Melo</surname><given-names>VC</given-names></name>, <name><surname>Mosimann</surname><given-names>AL</given-names></name>, <name><surname>Santos</surname><given-names>GI</given-names></name>, <name><surname>Santos</surname><given-names>CN</given-names></name>, <name><surname>Luz</surname><given-names>K</given-names></name>. <article-title>First report of autochthonous transmission of Zika virus in Brazil</article-title>. <source>Mem Inst Oswaldo Cruz</source>. <year>2015</year>;<volume>110</volume>(<issue>4</issue>):<fpage>569</fpage>&#x02013;<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/0074-02760150192">10.1590/0074-02760150192</ext-link></comment> .<?supplied-pmid 26061233?><pub-id pub-id-type="pmid">26061233</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Slavov</surname><given-names>SN</given-names></name>, <name><surname>Otaguiri</surname><given-names>KK</given-names></name>, <name><surname>Kashima</surname><given-names>S</given-names></name>, <name><surname>Covas</surname><given-names>DT</given-names></name>. <article-title>Overview of Zika virus (ZIKV) infection in regards to the Brazilian epidemic</article-title>. <source>Braz J Med Biol Res</source>. <year>2016</year>;<volume>49</volume>(<issue>5</issue>):<fpage>e5420</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/1414-431X20165420">10.1590/1414-431X20165420</ext-link></comment> .<?supplied-pmid 27143174?><pub-id pub-id-type="pmid">27143174</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Faria</surname><given-names>NR</given-names></name>, <name><surname>Quick</surname><given-names>J</given-names></name>, <name><surname>Claro</surname><given-names>IM</given-names></name>, <name><surname>Theze</surname><given-names>J</given-names></name>, <name><surname>de Jesus</surname><given-names>JG</given-names></name>, <name><surname>Giovanetti</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Establishment and cryptic transmission of Zika virus in Brazil and the Americas</article-title>. <source>Nature</source>. <year>2017</year>;<volume>546</volume>(<issue>7658</issue>):<fpage>406</fpage>&#x02013;<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature22401">10.1038/nature22401</ext-link></comment> .<?supplied-pmid 28538727?><pub-id pub-id-type="pmid">28538727</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref004"><label>4</label><mixed-citation publication-type="other">(WHO) WHO. Situation Report: Zika virus, Microcephaly, and Guillain-Barre Syndrome. Report. World Health Organization (WHO), 2017 March 9, 2017.</mixed-citation></ref><ref id="pntd.0006518.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Roze</surname><given-names>B</given-names></name>, <name><surname>Najioullah</surname><given-names>F</given-names></name>, <name><surname>Ferge</surname><given-names>JL</given-names></name>, <name><surname>Dorleans</surname><given-names>F</given-names></name>, <name><surname>Apetse</surname><given-names>K</given-names></name>, <name><surname>Barnay</surname><given-names>JL</given-names></name>, <etal>et al</etal>
<article-title>Guillain-Barre Syndrome Associated With Zika Virus Infection in Martinique in 2016: A Prospective Study</article-title>. <source>Clin Infect Dis</source>. <year>2017</year>;<volume>65</volume>(<issue>9</issue>):<fpage>1462</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cid/cix588">10.1093/cid/cix588</ext-link></comment> .<?supplied-pmid 29020245?><pub-id pub-id-type="pmid">29020245</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Krauer</surname><given-names>F</given-names></name>, <name><surname>Riesen</surname><given-names>M</given-names></name>, <name><surname>Reveiz</surname><given-names>L</given-names></name>, <name><surname>Oladapo</surname><given-names>OT</given-names></name>, <name><surname>Martinez-Vega</surname><given-names>R</given-names></name>, <name><surname>Porgo</surname><given-names>TV</given-names></name>, <etal>et al</etal>
<article-title>Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barre Syndrome: Systematic Review</article-title>. <source>PLoS Med</source>. <year>2017</year>;<volume>14</volume>(<issue>1</issue>):<fpage>e1002203</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.1002203">10.1371/journal.pmed.1002203</ext-link></comment> .<?supplied-pmid 28045901?><pub-id pub-id-type="pmid">28045901</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Bhadelia</surname><given-names>N</given-names></name>. <article-title>Prospective cohort study of pregnant Brazilian women elucidates link between Zika virus infection and fetal abnormalities</article-title>. <source>Evid Based Med</source>. <year>2016</year>;<volume>21</volume>(<issue>5</issue>):<fpage>193</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/ebmed-2016-110476">10.1136/ebmed-2016-110476</ext-link></comment> .<?supplied-pmid 27495823?><pub-id pub-id-type="pmid">27495823</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Reynolds</surname><given-names>MR</given-names></name>, <name><surname>Jones</surname><given-names>AM</given-names></name>, <name><surname>Petersen</surname><given-names>EE</given-names></name>, <name><surname>Lee</surname><given-names>EH</given-names></name>, <name><surname>Rice</surname><given-names>ME</given-names></name>, <name><surname>Bingham</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Vital Signs: Update on Zika Virus-Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure&#x02014;U.S. Zika Pregnancy Registry, 2016</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2017</year>;<volume>66</volume>(<issue>13</issue>):<fpage>366</fpage>&#x02013;<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15585/mmwr.mm6613e1">10.15585/mmwr.mm6613e1</ext-link></comment> .<?supplied-pmid 28384133?><pub-id pub-id-type="pmid">28384133</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Hurtado-Villa</surname><given-names>P</given-names></name>, <name><surname>Puerto</surname><given-names>AK</given-names></name>, <name><surname>Victoria</surname><given-names>S</given-names></name>, <name><surname>Gracia</surname><given-names>G</given-names></name>, <name><surname>Guasmayan</surname><given-names>L</given-names></name>, <name><surname>Arce</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Raised Frequency of Central Nervous System Malformations Related to Zika Virus Infection in Two Birth Defects Surveillance Systems in Bogota and Cali, Colombia</article-title>. <source>Pediatr Infect Dis J</source>. <year>2017</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/INF.0000000000001670">10.1097/INF.0000000000001670</ext-link></comment> .<?supplied-pmid 28678053?></mixed-citation></ref><ref id="pntd.0006518.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>McCloskey</surname><given-names>B</given-names></name>, <name><surname>Endericks</surname><given-names>T</given-names></name>. <article-title>The rise of Zika infection and microcephaly: what can we learn from a public health emergency?</article-title>
<source>Public Health</source>. <year>2017</year>;<volume>150</volume>:<fpage>87</fpage>&#x02013;<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.puhe.2017.05.008">10.1016/j.puhe.2017.05.008</ext-link></comment> .<?supplied-pmid 28651111?><pub-id pub-id-type="pmid">28651111</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref011"><label>11</label><mixed-citation publication-type="other">(PAHO) PAHO. Cumulative Zika report. 2017.</mixed-citation></ref><ref id="pntd.0006518.ref012"><label>12</label><mixed-citation publication-type="other">PAHO/WHO. Regional Zika Epidemiological Update (Americas) August 25, 2017. PAHO WHO, 2017 25/8/2017.</mixed-citation></ref><ref id="pntd.0006518.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Althaus</surname><given-names>CL</given-names></name>, <name><surname>Low</surname><given-names>N</given-names></name>. <article-title>How Relevant Is Sexual Transmission of Zika Virus?</article-title>
<source>PLoS Med</source>. <year>2016</year>;<volume>13</volume>(<issue>10</issue>):<fpage>e1002157</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.1002157">10.1371/journal.pmed.1002157</ext-link></comment> .<?supplied-pmid 27780196?><pub-id pub-id-type="pmid">27780196</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name><surname>Funk</surname><given-names>S</given-names></name>, <name><surname>Eggo</surname><given-names>RM</given-names></name>, <name><surname>Mallet</surname><given-names>HP</given-names></name>, <name><surname>Edmunds</surname><given-names>WJ</given-names></name>, <name><surname>Nilles</surname><given-names>EJ</given-names></name>. <article-title>Transmission Dynamics of Zika Virus in Island Populations: A Modelling Analysis of the 2013&#x02013;14 French Polynesia Outbreak</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2016</year>;<volume>10</volume>(<issue>5</issue>):<fpage>e0004726</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pntd.0004726">10.1371/journal.pntd.0004726</ext-link></comment> .<?supplied-pmid 27186984?><pub-id pub-id-type="pmid">27186984</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Sharma</surname><given-names>A</given-names></name>, <name><surname>Lal</surname><given-names>SK</given-names></name>. <article-title>Zika Virus: Transmission, Detection, Control, and Prevention</article-title>. <source>Front Microbiol</source>. <year>2017</year>;<volume>8</volume>:<fpage>110</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmicb.2017.00110">10.3389/fmicb.2017.00110</ext-link></comment> .<?supplied-pmid 28217114?><pub-id pub-id-type="pmid">28217114</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Krow-Lucal</surname><given-names>ER</given-names></name>, <name><surname>Novosad</surname><given-names>SA</given-names></name>, <name><surname>Dunn</surname><given-names>AC</given-names></name>, <name><surname>Brent</surname><given-names>CR</given-names></name>, <name><surname>Savage</surname><given-names>HM</given-names></name>, <name><surname>Faraji</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Zika Virus Infection in Patient with No Known Risk Factors, Utah, USA, 2016</article-title>. <source>Emerg Infect Dis</source>. <year>2017</year>;<volume>23</volume>(<issue>8</issue>):<fpage>1260</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid2308.170479">10.3201/eid2308.170479</ext-link></comment> .<?supplied-pmid 28726601?><pub-id pub-id-type="pmid">28726601</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Newman</surname><given-names>CM</given-names></name>, <name><surname>Dudley</surname><given-names>DM</given-names></name>, <name><surname>Aliota</surname><given-names>MT</given-names></name>, <name><surname>Weiler</surname><given-names>AM</given-names></name>, <name><surname>Barry</surname><given-names>GL</given-names></name>, <name><surname>Mohns</surname><given-names>MS</given-names></name>, <etal>et al</etal>
<article-title>Oropharyngeal mucosal transmission of Zika virus in rhesus macaques</article-title>. <source>Nature Communication</source>. <year>2017</year>;<volume>169</volume>(<issue>8</issue>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-017-00246-8">10.1038/s41467-017-00246-8</ext-link></comment>
<?supplied-pmid 28765581?><pub-id pub-id-type="pmid">28765581</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Duong</surname><given-names>V</given-names></name>, <name><surname>Lambrechts</surname><given-names>L</given-names></name>, <name><surname>Paul</surname><given-names>RE</given-names></name>, <name><surname>Ly</surname><given-names>S</given-names></name>, <name><surname>Lay</surname><given-names>RS</given-names></name>, <name><surname>Long</surname><given-names>KC</given-names></name>, <etal>et al</etal>
<article-title>Asymptomatic humans transmit dengue virus to mosquitoes</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2015</year>;<volume>112</volume>(<issue>47</issue>):<fpage>14688</fpage>&#x02013;<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1508114112">10.1073/pnas.1508114112</ext-link></comment> .<?supplied-pmid 26553981?><pub-id pub-id-type="pmid">26553981</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Nguyet</surname><given-names>MN</given-names></name>, <name><surname>Duong</surname><given-names>TH</given-names></name>, <name><surname>Trung</surname><given-names>VT</given-names></name>, <name><surname>Nguyen</surname><given-names>TH</given-names></name>, <name><surname>Tran</surname><given-names>CN</given-names></name>, <name><surname>Long</surname><given-names>VT</given-names></name>, <etal>et al</etal>
<article-title>Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2013</year>;<volume>110</volume>(<issue>22</issue>):<fpage>9072</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1303395110">10.1073/pnas.1303395110</ext-link></comment> .<?supplied-pmid 23674683?><pub-id pub-id-type="pmid">23674683</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Gupta</surname><given-names>P</given-names></name>, <name><surname>Mellors</surname><given-names>J</given-names></name>, <name><surname>Kingsley</surname><given-names>L</given-names></name>, <name><surname>Riddler</surname><given-names>S</given-names></name>, <name><surname>Singh</surname><given-names>MK</given-names></name>, <name><surname>Schreiber</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors</article-title>. <source>J Virol</source>. <year>1997</year>;<volume>71</volume>(<issue>8</issue>):<fpage>6271</fpage>&#x02013;<lpage>5</lpage>. .<?supplied-pmid 9223532?><pub-id pub-id-type="pmid">9223532</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Murray</surname><given-names>KO</given-names></name>, <name><surname>Gorchakov</surname><given-names>R</given-names></name>, <name><surname>Carlson</surname><given-names>AR</given-names></name>, <name><surname>Berry</surname><given-names>R</given-names></name>, <name><surname>Lai</surname><given-names>L</given-names></name>, <name><surname>Natrajan</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood</article-title>. <source>Emerg Infect Dis</source>. <year>2017</year>;<volume>23</volume>(<issue>1</issue>):<fpage>99</fpage>&#x02013;<lpage>101</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid2301.161394">10.3201/eid2301.161394</ext-link></comment> .<?supplied-pmid 27748649?><pub-id pub-id-type="pmid">27748649</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Harrower</surname><given-names>J</given-names></name>, <name><surname>Kiedrzynski</surname><given-names>T</given-names></name>, <name><surname>Baker</surname><given-names>S</given-names></name>, <name><surname>Upton</surname><given-names>A</given-names></name>, <name><surname>Rahnama</surname><given-names>F</given-names></name>, <name><surname>Sherwood</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Sexual Transmission of Zika Virus and Persistence in Semen, New Zealand, 2016</article-title>. <source>Emerg Infect Dis</source>. <year>2016</year>;<volume>22</volume>(<issue>10</issue>):<fpage>1855</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid2210.160951">10.3201/eid2210.160951</ext-link></comment> .<?supplied-pmid 27454745?><pub-id pub-id-type="pmid">27454745</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Bonaldo</surname><given-names>MC</given-names></name>, <name><surname>Ribeiro</surname><given-names>IP</given-names></name>, <name><surname>Lima</surname><given-names>NS</given-names></name>, <name><surname>Dos Santos</surname><given-names>AA</given-names></name>, <name><surname>Menezes</surname><given-names>LS</given-names></name>, <name><surname>da Cruz</surname><given-names>SO</given-names></name>, <etal>et al</etal>
<article-title>Isolation of Infective Zika Virus from Urine and Saliva of Patients in Brazil</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2016</year>;<volume>10</volume>(<issue>6</issue>):<fpage>e0004816</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pntd.0004816">10.1371/journal.pntd.0004816</ext-link></comment> .<?supplied-pmid 27341420?><pub-id pub-id-type="pmid">27341420</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Bingham</surname><given-names>AM</given-names></name>, <name><surname>Cone</surname><given-names>M</given-names></name>, <name><surname>Mock</surname><given-names>V</given-names></name>, <name><surname>Heberlein-Larson</surname><given-names>L</given-names></name>, <name><surname>Stanek</surname><given-names>D</given-names></name>, <name><surname>Blackmore</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Comparison of Test Results for Zika Virus RNA in Urine, Serum, and Saliva Specimens from Persons with Travel-Associated Zika Virus Disease&#x02014;Florida, 2016</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2016</year>;<volume>65</volume>(<issue>18</issue>):<fpage>475</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15585/mmwr.mm6518e2">10.15585/mmwr.mm6518e2</ext-link></comment> .<?supplied-pmid 27171533?><pub-id pub-id-type="pmid">27171533</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Landry</surname><given-names>ML</given-names></name>, <name><surname>St George</surname><given-names>K</given-names></name>. <article-title>Laboratory Diagnosis of Zika Virus Infection</article-title>. <source>Arch Pathol Lab Med</source>. <year>2017</year>;<volume>141</volume>(<issue>1</issue>):<fpage>60</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5858/arpa.2016-0406-SA">10.5858/arpa.2016-0406-SA</ext-link></comment> .<?supplied-pmid 27763787?><pub-id pub-id-type="pmid">27763787</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Baud</surname><given-names>D</given-names></name>, <name><surname>Gubler</surname><given-names>DJ</given-names></name>, <name><surname>Schaub</surname><given-names>B</given-names></name>, <name><surname>Lanteri</surname><given-names>MC</given-names></name>, <name><surname>Musso</surname><given-names>D</given-names></name>. <article-title>An update on Zika virus infection</article-title>. <source>Lancet</source>. <year>2017</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(17)31450-2">10.1016/S0140-6736(17)31450-2</ext-link></comment> .<?supplied-pmid 28647173?><pub-id pub-id-type="pmid">28647173</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Paz-Bailey</surname><given-names>G</given-names></name>, <name><surname>Rosenberg</surname><given-names>ES</given-names></name>, <name><surname>Doyle</surname><given-names>K</given-names></name>, <name><surname>Munoz-Jordan</surname><given-names>J</given-names></name>, <name><surname>Santiago</surname><given-names>GA</given-names></name>, <name><surname>Klein</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Persistence of Zika Virus in Body Fluids&#x02014;Preliminary Report</article-title>. <source>N Engl J Med</source>. <year>2017</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa1613108">10.1056/NEJMoa1613108</ext-link></comment> .<?supplied-pmid 28195756?><pub-id pub-id-type="pmid">28195756</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Barzon</surname><given-names>L</given-names></name>, <name><surname>Pacenti</surname><given-names>M</given-names></name>, <name><surname>Berto</surname><given-names>A</given-names></name>, <name><surname>Sinigaglia</surname><given-names>A</given-names></name>, <name><surname>Franchin</surname><given-names>E</given-names></name>, <name><surname>Lavezzo</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Isolation of infectious Zika virus from saliva and prolonged viral RNA shedding in a traveller returning from the Dominican Republic to Italy, January 2016</article-title>. <source>Euro Surveill</source>. <year>2016</year>;<volume>21</volume>(<issue>10</issue>):<fpage>30159</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2807/1560-7917.ES.2016.21.10.30159">10.2807/1560-7917.ES.2016.21.10.30159</ext-link></comment> .<?supplied-pmid 26987769?><pub-id pub-id-type="pmid">26987769</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Gourinat</surname><given-names>AC</given-names></name>, <name><surname>O&#x02019;Connor</surname><given-names>O</given-names></name>, <name><surname>Calvez</surname><given-names>E</given-names></name>, <name><surname>Goarant</surname><given-names>C</given-names></name>, <name><surname>Dupont-Rouzeyrol</surname><given-names>M</given-names></name>. <article-title>Detection of Zika virus in urine</article-title>. <source>Emerg Infect Dis</source>. <year>2015</year>;<volume>21</volume>(<issue>1</issue>):<fpage>84</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid2101.140894">10.3201/eid2101.140894</ext-link></comment> .<?supplied-pmid 25530324?><pub-id pub-id-type="pmid">25530324</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Musso</surname><given-names>D</given-names></name>, <name><surname>Roche</surname><given-names>C</given-names></name>, <name><surname>Nhan</surname><given-names>TX</given-names></name>, <name><surname>Robin</surname><given-names>E</given-names></name>, <name><surname>Teissier</surname><given-names>A</given-names></name>, <name><surname>Cao-Lormeau</surname><given-names>VM</given-names></name>. <article-title>Detection of Zika virus in saliva</article-title>. <source>J Clin Virol</source>. <year>2015</year>;<volume>68</volume>:<fpage>53</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jcv.2015.04.021">10.1016/j.jcv.2015.04.021</ext-link></comment> .<?supplied-pmid 26071336?><pub-id pub-id-type="pmid">26071336</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>D&#x02019;Ortenzio</surname><given-names>E</given-names></name>, <name><surname>Matheron</surname><given-names>S</given-names></name>, <name><surname>Yazdanpanah</surname><given-names>Y</given-names></name>, <name><surname>de Lamballerie</surname><given-names>X</given-names></name>, <name><surname>Hubert</surname><given-names>B</given-names></name>, <name><surname>Piorkowski</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Evidence of Sexual Transmission of Zika Virus</article-title>. <source>N Engl J Med</source>. <year>2016</year>;<volume>374</volume>(<issue>22</issue>):<fpage>2195</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMc1604449">10.1056/NEJMc1604449</ext-link></comment> .<?supplied-pmid 27074370?><pub-id pub-id-type="pmid">27074370</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Musso</surname><given-names>D</given-names></name>, <name><surname>Gubler</surname><given-names>DJ</given-names></name>. <article-title>Zika Virus</article-title>. <source>Clin Microbiol Rev</source>. <year>2016</year>;<volume>29</volume>(<issue>3</issue>):<fpage>487</fpage>&#x02013;<lpage>524</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/CMR.00072-15">10.1128/CMR.00072-15</ext-link></comment> .<?supplied-pmid 27029595?><pub-id pub-id-type="pmid">27029595</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Plourde</surname><given-names>AR</given-names></name>, <name><surname>Bloch</surname><given-names>EM</given-names></name>. <article-title>A Literature Review of Zika Virus</article-title>. <source>Emerg Infect Dis</source>. <year>2016</year>;<volume>22</volume>(<issue>7</issue>):<fpage>1185</fpage>&#x02013;<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid2207.151990">10.3201/eid2207.151990</ext-link></comment> .<?supplied-pmid 27070380?><pub-id pub-id-type="pmid">27070380</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Duffy</surname><given-names>MR</given-names></name>, <name><surname>Chen</surname><given-names>TH</given-names></name>, <name><surname>Hancock</surname><given-names>WT</given-names></name>, <name><surname>Powers</surname><given-names>AM</given-names></name>, <name><surname>Kool</surname><given-names>JL</given-names></name>, <name><surname>Lanciotti</surname><given-names>RS</given-names></name>, <etal>et al</etal>
<article-title>Zika virus outbreak on Yap Island, Federated States of Micronesia</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>360</volume>(<issue>24</issue>):<fpage>2536</fpage>&#x02013;<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa0805715">10.1056/NEJMoa0805715</ext-link></comment> .<?supplied-pmid 19516034?><pub-id pub-id-type="pmid">19516034</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Ioos</surname><given-names>S</given-names></name>, <name><surname>Mallet</surname><given-names>HP</given-names></name>, <name><surname>Leparc Goffart</surname><given-names>I</given-names></name>, <name><surname>Gauthier</surname><given-names>V</given-names></name>, <name><surname>Cardoso</surname><given-names>T</given-names></name>, <name><surname>Herida</surname><given-names>M</given-names></name>. <article-title>Current Zika virus epidemiology and recent epidemics</article-title>. <source>Med Mal Infect</source>. <year>2014</year>;<volume>44</volume>(<issue>7</issue>):<fpage>302</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.medmal.2014.04.008">10.1016/j.medmal.2014.04.008</ext-link></comment> .<?supplied-pmid 25001879?><pub-id pub-id-type="pmid">25001879</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>de Laval</surname><given-names>F</given-names></name>, <name><surname>Matheus</surname><given-names>S</given-names></name>, <name><surname>Maquart</surname><given-names>M</given-names></name>, <name><surname>Yvrard</surname><given-names>E</given-names></name>, <name><surname>Barthes</surname><given-names>N</given-names></name>, <name><surname>Combes</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Prospective Zika virus disease cohort: systematic screening</article-title>. <source>Lancet</source>. <year>2016</year>;<volume>388</volume>(<issue>10047</issue>):<fpage>868</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(16)31429-5">10.1016/S0140-6736(16)31429-5</ext-link></comment> .<?supplied-pmid 27597462?><pub-id pub-id-type="pmid">27597462</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Gallian</surname><given-names>P</given-names></name>, <name><surname>Cabie</surname><given-names>A</given-names></name>, <name><surname>Richard</surname><given-names>P</given-names></name>, <name><surname>Paturel</surname><given-names>L</given-names></name>, <name><surname>Charrel</surname><given-names>RN</given-names></name>, <name><surname>Pastorino</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Zika virus in asymptomatic blood donors in Martinique</article-title>. <source>Blood</source>. <year>2017</year>;<volume>129</volume>(<issue>2</issue>):<fpage>263</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1182/blood-2016-09-737981">10.1182/blood-2016-09-737981</ext-link></comment> .<?supplied-pmid 27827826?><pub-id pub-id-type="pmid">27827826</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Dasgupta</surname><given-names>S</given-names></name>, <name><surname>Reagan-Steiner</surname><given-names>S</given-names></name>, <name><surname>Goodenough</surname><given-names>D</given-names></name>, <name><surname>Russell</surname><given-names>K</given-names></name>, <name><surname>Tanner</surname><given-names>M</given-names></name>, <name><surname>Lewis</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Patterns in Zika Virus Testing and Infection, by Report of Symptoms and Pregnancy Status&#x02014;United States, January 3-March 5, 2016</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2016</year>;<volume>65</volume>(<issue>15</issue>):<fpage>395</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15585/mmwr.mm6515e1">10.15585/mmwr.mm6515e1</ext-link></comment> .<?supplied-pmid 27101541?><pub-id pub-id-type="pmid">27101541</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Reyes</surname><given-names>M</given-names></name>, <name><surname>Mercado</surname><given-names>JC</given-names></name>, <name><surname>Standish</surname><given-names>K</given-names></name>, <name><surname>Matute</surname><given-names>JC</given-names></name>, <name><surname>Ortega</surname><given-names>O</given-names></name>, <name><surname>Moraga</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Index cluster study of dengue virus infection in Nicaragua</article-title>. <source>Am J Trop Med Hyg</source>. <year>2010</year>;<volume>83</volume>(<issue>3</issue>):<fpage>683</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4269/ajtmh.2010.10-0023">10.4269/ajtmh.2010.10-0023</ext-link></comment> .<?supplied-pmid 20810839?><pub-id pub-id-type="pmid">20810839</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Beckett</surname><given-names>CG</given-names></name>, <name><surname>Kosasih</surname><given-names>H</given-names></name>, <name><surname>Faisal</surname><given-names>I</given-names></name>, <name><surname>Nurhayati</surname></name>, <name><surname>Tan</surname><given-names>R</given-names></name>, <name><surname>Widjaja</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Early detection of dengue infections using cluster sampling around index cases</article-title>. <source>Am J Trop Med Hyg</source>. <year>2005</year>;<volume>72</volume>(<issue>6</issue>):<fpage>777</fpage>&#x02013;<lpage>82</lpage>. .<?supplied-pmid 15967759?><pub-id pub-id-type="pmid">15967759</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Mammen</surname><given-names>MP</given-names></name>, <name><surname>Pimgate</surname><given-names>C</given-names></name>, <name><surname>Koenraadt</surname><given-names>CJ</given-names></name>, <name><surname>Rothman</surname><given-names>AL</given-names></name>, <name><surname>Aldstadt</surname><given-names>J</given-names></name>, <name><surname>Nisalak</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Spatial and temporal clustering of dengue virus transmission in Thai villages</article-title>. <source>PLoS Med</source>. <year>2008</year>;<volume>5</volume>(<issue>11</issue>):<fpage>e205</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.0050205">10.1371/journal.pmed.0050205</ext-link></comment> .<?supplied-pmid 18986209?><pub-id pub-id-type="pmid">18986209</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Riley</surname><given-names>S</given-names></name>. <article-title>A prospective study of spatial clusters gives valuable insights into dengue transmission</article-title>. <source>PLoS Med</source>. <year>2008</year>;<volume>5</volume>(<issue>11</issue>):<fpage>e220</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.0050220">10.1371/journal.pmed.0050220</ext-link></comment> .<?supplied-pmid 18998766?><pub-id pub-id-type="pmid">18998766</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Lozier</surname><given-names>MJ</given-names></name>, <name><surname>Burke</surname><given-names>RM</given-names></name>, <name><surname>Lopez</surname><given-names>J</given-names></name>, <name><surname>Acevedo</surname><given-names>V</given-names></name>, <name><surname>Amador</surname><given-names>M</given-names></name>, <name><surname>Read</surname><given-names>JS</given-names></name>, <etal>et al</etal>
<article-title>Differences in prevalence of symptomatic Zika virus infection by age and sex-Puerto Rico, 2016</article-title>. <source>J Infect Dis</source>. <year>2017</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/infdis/jix630">10.1093/infdis/jix630</ext-link></comment> .<?supplied-pmid 29216376?><pub-id pub-id-type="pmid">29216376</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Kuan</surname><given-names>G</given-names></name>, <name><surname>Gordon</surname><given-names>A</given-names></name>, <name><surname>Aviles</surname><given-names>W</given-names></name>, <name><surname>Ortega</surname><given-names>O</given-names></name>, <name><surname>Hammond</surname><given-names>SN</given-names></name>, <name><surname>Elizondo</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases</article-title>. <source>Am J Epidemiol</source>. <year>2009</year>;<volume>170</volume>(<issue>1</issue>):<fpage>120</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/aje/kwp092">10.1093/aje/kwp092</ext-link></comment> .<?supplied-pmid 19435864?><pub-id pub-id-type="pmid">19435864</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Waggoner</surname><given-names>JJ</given-names></name>, <name><surname>Gresh</surname><given-names>L</given-names></name>, <name><surname>Mohamed-Hadley</surname><given-names>A</given-names></name>, <name><surname>Ballesteros</surname><given-names>G</given-names></name>, <name><surname>Davila</surname><given-names>MJ</given-names></name>, <name><surname>Tellez</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Single-Reaction Multiplex Reverse Transcription PCR for Detection of Zika, Chikungunya, and Dengue Viruses</article-title>. <source>Emerg Infect Dis</source>. <year>2016</year>;<volume>22</volume>(<issue>7</issue>):<fpage>1295</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid2207.160326">10.3201/eid2207.160326</ext-link></comment> .<?supplied-pmid 27184629?><pub-id pub-id-type="pmid">27184629</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Balmaseda</surname><given-names>A</given-names></name>, <name><surname>Gordon</surname><given-names>A</given-names></name>, <name><surname>Gresh</surname><given-names>L</given-names></name>, <name><surname>Ojeda</surname><given-names>S</given-names></name>, <name><surname>Saborio</surname><given-names>S</given-names></name>, <name><surname>Tellez</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Clinical Attack Rate of Chikungunya in a Cohort of Nicaraguan Children</article-title>. <source>Am J Trop Med Hyg</source>. <year>2016</year>;<volume>94</volume>(<issue>2</issue>):<fpage>397</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4269/ajtmh.15-0413">10.4269/ajtmh.15-0413</ext-link></comment> .<?supplied-pmid 26643531?><pub-id pub-id-type="pmid">26643531</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Galo</surname><given-names>SS</given-names></name>, <name><surname>Gonzalez</surname><given-names>K</given-names></name>, <name><surname>Tellez</surname><given-names>Y</given-names></name>, <name><surname>Garcia</surname><given-names>N</given-names></name>, <name><surname>Perez</surname><given-names>L</given-names></name>, <name><surname>Gresh</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Development of in-house serological methods for diagnosis and surveillance of chikungunya</article-title>. <source>Rev Panam Salud Publica</source>. <year>2017</year>;<volume>41</volume>:<fpage>e56</fpage> .<?supplied-pmid 28902269?><pub-id pub-id-type="pmid">28902269</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Balmaseda</surname><given-names>A</given-names></name>, <name><surname>Zambrana</surname><given-names>JV</given-names></name>, <name><surname>Collado</surname><given-names>D</given-names></name>, <name><surname>Garcia</surname><given-names>N</given-names></name>, <name><surname>Saborio</surname><given-names>S</given-names></name>, <name><surname>Elizondo</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Comparison of Four Serological Methods and Two Reverse Transcription-PCR Assays for Diagnosis and Surveillance of Zika Virus Infection</article-title>. <source>J Clin Microbiol</source>. <year>2018</year>;<volume>56</volume>(<issue>3</issue>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JCM.01785-17">10.1128/JCM.01785-17</ext-link></comment> .<?supplied-pmid 29305550?><pub-id pub-id-type="pmid">29305550</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Balmaseda</surname><given-names>A</given-names></name>, <name><surname>Guzman</surname><given-names>MG</given-names></name>, <name><surname>Hammond</surname><given-names>S</given-names></name>, <name><surname>Robleto</surname><given-names>G</given-names></name>, <name><surname>Flores</surname><given-names>C</given-names></name>, <name><surname>Tellez</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva</article-title>. <source>Clin Diagn Lab Immunol</source>. <year>2003</year>;<volume>10</volume>(<issue>2</issue>):<fpage>317</fpage>&#x02013;<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/CDLI.10.2.317-322.2003">10.1128/CDLI.10.2.317-322.2003</ext-link></comment> .<?supplied-pmid 12626461?><pub-id pub-id-type="pmid">12626461</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Sabor&#x000ed;o Galo</surname><given-names>S</given-names></name>, <name><surname>Gonz&#x000e1;lez</surname><given-names>K</given-names></name>, <name><surname>T&#x000e9;llez</surname><given-names>Y</given-names></name>, <name><surname>Garc&#x000ed;a</surname><given-names>N</given-names></name>, <name><surname>P&#x000e9;rez</surname><given-names>L</given-names></name>, <name><surname>Gresh</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Development of in-house serological methods for diagnosis and surveillance of chikungunya</article-title>. <source>Pan Am J Public Health</source>. <year>2017</year>;<volume>41</volume>(<issue>56</issue>).</mixed-citation></ref><ref id="pntd.0006518.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Stettler</surname><given-names>K</given-names></name>, <name><surname>Beltramello</surname><given-names>M</given-names></name>, <name><surname>Espinosa</surname><given-names>DA</given-names></name>, <name><surname>Graham</surname><given-names>V</given-names></name>, <name><surname>Cassotta</surname><given-names>A</given-names></name>, <name><surname>Bianchi</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection</article-title>. <source>Science</source>. <year>2016</year>;<volume>353</volume>(<issue>6301</issue>):<fpage>823</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.aaf8505">10.1126/science.aaf8505</ext-link></comment> .<?supplied-pmid 27417494?><pub-id pub-id-type="pmid">27417494</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Clarke</surname><given-names>DH</given-names></name>, <name><surname>Casals</surname><given-names>J</given-names></name>. <article-title>Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses</article-title>. <source>Am J Trop Med Hyg</source>. <year>1958</year>;<volume>7</volume>(<issue>5</issue>):<fpage>561</fpage>&#x02013;<lpage>73</lpage>. .<?supplied-pmid 13571577?><pub-id pub-id-type="pmid">13571577</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Vazquez-Prokopec</surname><given-names>GM</given-names></name>, <name><surname>Galvin</surname><given-names>WA</given-names></name>, <name><surname>Kelly</surname><given-names>R</given-names></name>, <name><surname>Kitron</surname><given-names>U</given-names></name>. <article-title>A new, cost-effective, battery-powered aspirator for adult mosquito collections</article-title>. <source>J Med Entomol</source>. <year>2009</year>;<volume>46</volume>(<issue>6</issue>):<fpage>1256</fpage>&#x02013;<lpage>9</lpage>. .<?supplied-pmid 19960668?><pub-id pub-id-type="pmid">19960668</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Andersson</surname><given-names>N</given-names></name>, <name><surname>Nava-Aguilera</surname><given-names>E</given-names></name>, <name><surname>Arostegui</surname><given-names>J</given-names></name>, <name><surname>Morales-Perez</surname><given-names>A</given-names></name>, <name><surname>Suazo-Laguna</surname><given-names>H</given-names></name>, <name><surname>Legorreta-Soberanis</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Evidence based community mobilization for dengue prevention in Nicaragua and Mexico (Camino Verde, the Green Way): cluster randomized controlled trial</article-title>. <source>Bmj</source>. <year>2015</year>;<volume>351</volume>:<fpage>h3267</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.h3267">10.1136/bmj.h3267</ext-link></comment> .<?supplied-pmid 26156323?><pub-id pub-id-type="pmid">26156323</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref055"><label>55</label><mixed-citation publication-type="book"><collab>Team RC</collab>. <source>R: A language and environment for statistical computing</source>. <publisher-name>R Foundation for Statistical Computing</publisher-name>
<publisher-loc>Vienna, Austria</publisher-loc>
<year>2017</year>.</mixed-citation></ref><ref id="pntd.0006518.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Zou</surname><given-names>GY</given-names></name>, <name><surname>Donner</surname><given-names>A</given-names></name>. <article-title>Extension of the modified Poisson regression model to prospective studies with correlated binary data</article-title>. <source>Stat Methods Med Res</source>. <year>2013</year>;<volume>22</volume>(<issue>6</issue>):<fpage>661</fpage>&#x02013;<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/0962280211427759">10.1177/0962280211427759</ext-link></comment> .<?supplied-pmid 22072596?><pub-id pub-id-type="pmid">22072596</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Driggers</surname><given-names>RW</given-names></name>, <name><surname>Ho</surname><given-names>CY</given-names></name>, <name><surname>Korhonen</surname><given-names>EM</given-names></name>, <name><surname>Kuivanen</surname><given-names>S</given-names></name>, <name><surname>Jaaskelainen</surname><given-names>AJ</given-names></name>, <name><surname>Smura</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities</article-title>. <source>N Engl J Med</source>. <year>2016</year>;<volume>374</volume>(<issue>22</issue>):<fpage>2142</fpage>&#x02013;<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa1601824">10.1056/NEJMoa1601824</ext-link></comment> .<?supplied-pmid 27028667?><pub-id pub-id-type="pmid">27028667</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Dudley</surname><given-names>DM</given-names></name>, <name><surname>Aliota</surname><given-names>MT</given-names></name>, <name><surname>Mohr</surname><given-names>EL</given-names></name>, <name><surname>Weiler</surname><given-names>AM</given-names></name>, <name><surname>Lehrer-Brey</surname><given-names>G</given-names></name>, <name><surname>Weisgrau</surname><given-names>KL</given-names></name>, <etal>et al</etal>
<article-title>A rhesus macaque model of Asian-lineage Zika virus infection</article-title>. <source>Nat Commun</source>. <year>2016</year>;<volume>7</volume>:<fpage>12204</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms12204">10.1038/ncomms12204</ext-link></comment> .<?supplied-pmid 27352279?><pub-id pub-id-type="pmid">27352279</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Adams Waldorf</surname><given-names>KM</given-names></name>, <name><surname>Stencel-Baerenwald</surname><given-names>JE</given-names></name>, <name><surname>Kapur</surname><given-names>RP</given-names></name>, <name><surname>Studholme</surname><given-names>C</given-names></name>, <name><surname>Boldenow</surname><given-names>E</given-names></name>, <name><surname>Vornhagen</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Fetal brain lesions after subcutaneous inoculation of Zika virus in a pregnant nonhuman primate</article-title>. <source>Nat Med</source>. <year>2016</year>;<volume>22</volume>(<issue>11</issue>):<fpage>1256</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm.4193">10.1038/nm.4193</ext-link></comment> .<?supplied-pmid 27618651?><pub-id pub-id-type="pmid">27618651</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Lozier</surname><given-names>MJ</given-names></name>, <name><surname>Rosenberg</surname><given-names>ES</given-names></name>, <name><surname>Doyle</surname><given-names>K</given-names></name>, <name><surname>Adams</surname><given-names>L</given-names></name>, <name><surname>Klein</surname><given-names>L</given-names></name>, <name><surname>Munoz-Jordan</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Prolonged detection of Zika virus nucleic acid among symptomatic pregnant women: a cohort study</article-title>. <source>Clin Infect Dis</source>. <year>2018</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cid/ciy209">10.1093/cid/ciy209</ext-link></comment> .<?supplied-pmid 29534160?><pub-id pub-id-type="pmid">29534160</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Krow-Lucal</surname><given-names>ER</given-names></name>, <name><surname>Biggerstaff</surname><given-names>BJ</given-names></name>, <name><surname>Staples</surname><given-names>JE</given-names></name>. <article-title>Estimated Incubation Period for Zika Virus Disease</article-title>. <source>Emerg Infect Dis</source>. <year>2017</year>;<volume>23</volume>(<issue>5</issue>):<fpage>841</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid2305.161715">10.3201/eid2305.161715</ext-link></comment> .<?supplied-pmid 28277198?><pub-id pub-id-type="pmid">28277198</pub-id></mixed-citation></ref><ref id="pntd.0006518.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Marcondes</surname><given-names>CB</given-names></name>, <name><surname>Ximenes Mde</surname><given-names>F</given-names></name>. <article-title>Zika virus in Brazil and the danger of infestation by Aedes (Stegomyia) mosquitoes</article-title>. <source>Rev Soc Bras Med Trop</source>. <year>2016</year>;<volume>49</volume>(<issue>1</issue>):<fpage>4</fpage>&#x02013;<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/0037-8682-0220-2015">10.1590/0037-8682-0220-2015</ext-link></comment> .<?supplied-pmid 26689277?><pub-id pub-id-type="pmid">26689277</pub-id></mixed-citation></ref></ref-list></back></article>